CA2682761C - Methods for rapid multiplexed amplification of target nucleic acids - Google Patents

Methods for rapid multiplexed amplification of target nucleic acids Download PDF

Info

Publication number
CA2682761C
CA2682761C CA2682761A CA2682761A CA2682761C CA 2682761 C CA2682761 C CA 2682761C CA 2682761 A CA2682761 A CA 2682761A CA 2682761 A CA2682761 A CA 2682761A CA 2682761 C CA2682761 C CA 2682761C
Authority
CA
Canada
Prior art keywords
biochip
sec
reaction
nucleic acid
reactions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2682761A
Other languages
French (fr)
Other versions
CA2682761A1 (en
Inventor
Richard F. Selden
Eugene Tan
Heung C. Lam
Heidi S. Giese
Gregory J. Kellogg
John A. Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ande Corp
Original Assignee
Netbio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Netbio Inc filed Critical Netbio Inc
Priority to CA2894945A priority Critical patent/CA2894945C/en
Publication of CA2682761A1 publication Critical patent/CA2682761A1/en
Application granted granted Critical
Publication of CA2682761C publication Critical patent/CA2682761C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L7/00Heating or cooling apparatus; Heat insulating devices
    • B01L7/52Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502715Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/50273Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the means or forces applied to move the fluids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502753Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6402Atomic fluorescence; Laser induced fluorescence
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/645Specially adapted constructive features of fluorimeters
    • G01N21/6452Individual samples arranged in a regular 2D-array, e.g. multiwell plates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6486Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • G01N27/44704Details; Accessories
    • G01N27/44717Arrangements for investigating the separated zones, e.g. localising zones
    • G01N27/44721Arrangements for investigating the separated zones, e.g. localising zones by optical means
    • G01N27/44726Arrangements for investigating the separated zones, e.g. localising zones by optical means using specific dyes, markers or binding molecules
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • G01N27/44704Details; Accessories
    • G01N27/44743Introducing samples
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • G01N27/44756Apparatus specially adapted therefor
    • G01N27/44782Apparatus specially adapted therefor of a plurality of samples
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416Systems
    • G01N27/447Systems using electrophoresis
    • G01N27/44756Apparatus specially adapted therefor
    • G01N27/44791Microapparatus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06Fluid handling related problems
    • B01L2200/0684Venting, avoiding backpressure, avoid gas bubbles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/10Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/14Process control and prevention of errors
    • B01L2200/143Quality control, feedback systems
    • B01L2200/147Employing temperature sensors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/0627Sensor or part of a sensor is integrated
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/0627Sensor or part of a sensor is integrated
    • B01L2300/0654Lenses; Optical fibres
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/069Absorbents; Gels to retain a fluid
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0809Geometry, shape and general structure rectangular shaped
    • B01L2300/0816Cards, e.g. flat sample carriers usually with flow in two horizontal directions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0809Geometry, shape and general structure rectangular shaped
    • B01L2300/0819Microarrays; Biochips
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0861Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0864Configuration of multiple channels and/or chambers in a single devices comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0887Laminated structure
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/16Surface properties and coatings
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/18Means for temperature control
    • B01L2300/1805Conductive heating, heat from thermostatted solids is conducted to receptacles, e.g. heating plates, blocks
    • B01L2300/1822Conductive heating, heat from thermostatted solids is conducted to receptacles, e.g. heating plates, blocks using Peltier elements
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/18Means for temperature control
    • B01L2300/1838Means for temperature control using fluid heat transfer medium
    • B01L2300/1844Means for temperature control using fluid heat transfer medium using fans
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/18Means for temperature control
    • B01L2300/1894Cooling means; Cryo cooling
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0403Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0415Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic
    • B01L2400/0421Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic electrophoretic flow
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G01N2021/6439Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
    • G01N2021/6441Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks with two or more labels
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2201/00Features of devices classified in G01N21/00
    • G01N2201/06Illumination; Optics
    • G01N2201/061Sources
    • G01N2201/06113Coherent sources; lasers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2575Volumetric liquid transfer

Abstract

A fast, multiplexed PCR system is described that can rapidly generate amplified nucleic acid products, for example, a full STR profile, from a target nucleic acid. Such systems include, for example, microfluidic biochips and a custom built thermal cycler, which are also described. The resulting STR profiles can satisfy forensic guidelines for signal strength, inter-loci peak height balance, heterozygous peak height ratio, incomplete non-template nucleotide addition, and stutter.

Description

METHODS FOR RAPID MULTIPLEXED AMPLIFICATION OF TARGET NUCLEIC ACIDS

FIELD OF THE INVENTION
The present invention generally relates to methods for the rapid amplification of one or more loci within a nucleic acid sample, as well as thermal cyclers and systems useful for performing the methods.
BACKGROUND OF THE INVENTION
The polymerase chain reaction (PCR) is an enzymatic reaction that facilitates rapid exponential amplification of nucleic acid sequences in vitro. In forensics, PCR can be utilized to identify individuals based on the amplification of small regions of the human genome containing a class of repeated DNA known as Short Tandem Repeats (STRs). The unit length of a given STR repeat ranges between 2-10 base pairs, and STRs generally fall within non-coding and flanking sequences but occasionally within coding regions (Edwards et al., Am. J. Hum. Genet. 1991, 49, 746-756). There are several hundred thousand STR loci in the human genome, occurring on average every 6-10 kb (Beckman and Weber, Genomics 1992, 12, 627-631) and appearing to be highly polymorphic (Edwards et al., Trans. Assoc.
Am. Physicians 1989, 102, 185-194). STR analysis has become a major tool in the forensic armamentarium with a growing set of applications including paternity testing, human identification in mass disasters, and routine typing of children.
While several commercially available STR kits have been developed for synthesizing the desired PCR products with high specificity, there are significant areas in which current STR technologies can be improved. Most importantly, the average time to complete multiplex PCR using commercial STR typing kits is approximately 2.14 hours;
the time-consuming and labor-intensive nature of these assays has contributed to backlogs in forensic laboratories. While the advent of automated instrumentation to simultaneously process multiple samples has helped to alleviate a significant bottleneck in typing throughput, the increasing number of samples to be analyzed will require further acceleration of the process. Furthermore, there is a need to increase the sensitivity of STR
assays as well as to improve the detection of the amplified products (Gill, Croat. Med. J. 2001, 42, 229-32).
Currently available STR kits contain nine to sixteen loci and work is underway in the field to increase the number of loci that can be detected. Certain applications of STR
analysis in the field can be conducted using 4 or more loci.
PCR can also be applied in a wide range of clinical settings. For example, PCR
can be utilized to diagnose bacterial infections such as those caused by Group A
Streptococci, methicillin resistant S. aureus, and vancomycin resistant Enterococci and is generally more sensitive than culture-based diagnostic techniques. Fungal infections can be similarly diagnosed. PCR can be used to diagnose respiratory viruses (e.g., respiratory syncytial virus, adenovirus, and influenza and parainfluenza viruses), genito-urinary viruses (e.g., herpes simplex virus and typing human papilloma viruses), meningitis (e.g., herpes simplex virus, Epstein-Barr virus, varicella-zoster virus, and enteroviruses), and hepatitis (e.g., hepatitis B
and C). PCR is also useful in preimplantation genetic diagnosis including the assessment of aneuploidy as well as the diagnosis of inherited diseases. From oncology to rheumatology and from hematology to gastroenterology, it would be difficult to find an area of medicine not impacted by PCR.
PCR has also been applied in a variety of non-clinical settings including veterinary identification (analogous to human STR typing), veterinary diagnostics, assessment of food safety, detection of agricultural pathogens and pharmacogenomics. An application of growing importance concerns the identification of biological weapons agents in clinical and environmental samples. Real-time PCR, a close relative of PCR that allows quantitation of the amount of product present in a reaction following each amplification cycle, is utilized in essentially the same applications as PCR itself (see, Espy et al., Clinical Microbiology Reviews 2006, 19, 1656-256).
Most commercially available thermal cycling instruments are limited in that they receive temperature feedback directly from and control the block temperature as opposed to the PCR solution temperature. As a consequence, the temperature profile of the solution,
2 which is critical to the success of the PCR, is likely to be grossly different from the desired profile.
Moreover, much of the literature on increasing PCR speed and sensitivity has focused on amplification of one particular locus at a time ("singleplex assays") and only limited success has been reported in simultaneous amplification of multiple loci ("multiplex assays") as required for forensic STR typing, clinical diagnostic and non-clinical applications. For example, a 160 nL chamber coupled to an integrated heater has been shown to be capable of amplification and separation of 4 STRs contained in a Y-STR assay in 80 minutes with a detection limit of 20 copies of template DNA. (Liu et al., Anal. Chem. 2007, 79, 1881-1889).
Increased PCR sensitivity due to reduced PCR reaction volume has also been reported for the PowerPlex 16 System, although no attempt was made to increase reaction speed (Schmidt et al., Int. J. Legal Med. 2006, 120, 42-48). However, neither report provided for the significantly shorter amplification times needed in the art. Hopwood et al., (International Congress Series 1288 (2006) 639-641) report a one hundred minute amplification using a set of 11 STR primers. With respect to clinical diagnostics, a panel of seven common respiratory viruses was amplified using a nanochip system in a PCR assay requiring 97.5 minutes (Takahashi et al., J. Clin. Microbiol 2008, doi:10.1128/JCM.01947-07).
Many of the applications of PCR (and real time PCR) such as forensic human identification by STR typing, clinical diagnostics, and biological weapons agent detection are extremely time sensitive and many of the applications are best performed in a multiplex setting. In addition, many of these applications are utilized in settings in which limited sample is available (e.g., a small number of pathogens from a clinical or environmental sample or a small number of human cells from a forensic sample) and sensitivity of the reaction is critical.
Notably, Horsman et al., (J.Forensic Sci., 2007, 52, 784-799) Id. at 792 stated that "PCR has been a common pursuit among analytical microchip researchers, as demonstrated by the wealth of literature on the topic. However, for forensic DNA analysis, there remain a number of avenues for development. Extensive work has not been shown using the commercially available forensic STR kits or, further, multiple STR
amplifications on a single device. When fully developed, however, microchip PCR will undoubtedly be a considerable time and cost savings to the forensic community." Therefore, there exists a need in the art for rapid and sensitive methods to successfully provide simultaneous amplification of a plurality of loci within a nucleic acid sample for a broad range of applications.
3 SUMMARY OF THE INVENTION
The instruments, biochips, methods and systems of the invention provide the capability of heating and cooling a PCR solution rapidly, controllably, and reproducibly through monitoring and controlling the thermal cycler based on, at least in part, the actual temperature of the solution. The inventive instruments, biochips, methods and systems disclosed herein provide the ability to monitor and/or accurately control the reaction temperature of a solution within a biochip to avoid over- or under-heating through the specific incorporation of thermosensors that are not present in commercial thermal cyclers.
The ability to rapidly heat and cool reaction solutions to such temperatures allows ramping and settling times to be minimized and incubation time at the desired temperature to dominate the total step time. Further, the instruments, biochips, methods and systems of the invention provided herein impart the ability to rapidly alter and equilibrate the temperature of a reaction solution, thereby greatly increasing the speed at which an amplification reaction may proceed.
Fast multiplex PCR amplification times as short as seventeen minutes have been achieved using instruments, biochips, methods and systems of the invention.
Additional time reductions are possible based on the teachings of this invention. Further, the fast PCR
methods of the invention are effective over a wide dynamic range, are extremely sensitive and are compatible with a wide range of commercially available enzymes and reagents. For forensic applications, the instruments, biochips, methods and systems of the invention enable significant reductions in the time required to generate full profiles that satisfy interpretation guidelines for STR analysis.
In a first aspect, the invention provides thermal cyclers comprising a temperature control element (TCE) wherein a first surface of said TCE is adapted to receive a sample chamber containing a solution and a sensing chamber containing a thermosensor, wherein the thermosensor provides feedback to the TCE to set or maintain the sample at a desired temperature. In a second aspect, the invention provides thermal cyclers further comprising a second thermosensor positioned to monitor the temperature of the first surface of the TCE.
In a second aspect, the invention provides systems comprising a biochip comprising one or a plurality of reaction chambers comprising a portion of the biochip having a volume, wherein each reaction chamber further comprises a microfluidic inlet channel and a microfluidic outlet channel, wherein each reaction chamber is less than 200 tim from a contact surface of the biochip substrate; the system further comprising a thermal cycler,
4 comprising a temperature control element (TCE) wherein a first surface of the TCE is adapted to receive a substrate containing a sample, and a thermosensor positioned to measure the temperature of sample in the substrate and provide feedback to the TCE to set or maintain the sample at a desired temperature said thermal cycler in thermal communication with the contact surface of the biochip substrate.
In a third aspect, the invention provides systems comprising a biochip, comprising one or a plurality of reaction chambers, wherein each reaction chamber comprising a portion of the biochip having a volume, further comprising a microfluidic inlet channel and a microfluidic outlet channel, wherein each reaction chamber is less than 100 itm from a contact surface of the biochip substrate; and a thermal cycler, comprising a temperature control element (TCE) wherein a first surface of the TCE is adapted to receive a substrate containing a sample, and a thermosensor positioned to measure the temperature of sample in the substrate and provide feedback to the TCE to set or maintain the sample at a desired temperature, said thermal cycler in thermal communication with the contact surface of the biochip substrate.
In a fourth aspect, the invention provides methods for simultaneously amplifying of a plurality of loci in a nucleic acid solution comprising providing one or a plurality of reaction chambers wherein each reaction chamber comprises (i) a nucleic acid solution comprising at least one copy of at least one target nucleic acid to be amplified; (ii) one or more buffers; (iii) one or more salts; (iv) a primer set corresponding to each of the plurality of loci to be amplified; (v) a nucleic acid polymerase; and (vi) nucleotides, sequentially thermally cycling the temperature of the nucleic acid solution in each reaction chamber between a denaturing state, an annealing state, and an extension state for a predetermined number of cycles at heating and a cooling rates of about 4 ĀØ 150 C/sec, to yield a plurality of amplified loci in each reaction chamber in about 97 minutes or less.
In a fifth aspect, the invention provides methods for simultaneously amplifying of a plurality of loci in a nucleic acid solution comprising providing one or a plurality of reaction chambers wherein each reaction chamber comprises (i) a nucleic acid solution comprising at least one copy of at least one target nucleic acid to be amplified; (ii) one or more buffers; (iii) one or more salts; (iv) a primer set corresponding to each of the plurality of loci to be amplified; (v) a nucleic acid polymerase; and (vi) nucleotides, sequentially thermally cycling the temperature of the nucleic acid solution in each reaction chamber for a predetermined
5
6 number of cycles at heating and a cooling rates of about 4 ĀØ 150 C/sec, to yield a plurality of amplified loci in each reaction chamber in about 97 minutes or less.
In a sixth aspect, the invention provides methods for simultaneously amplifying 5 or more loci in a nucleic acid solution comprising providing one or a plurality of reaction chambers wherein each reaction chamber comprises (i) a nucleic acid solution comprising at least one copy of at least one target nucleic acid to be amplified; (ii) one or more buffers; (iii) one or more salts; (iv) a primer set corresponding to the 5 or more loci to be amplified; (v) a nucleic acid polymerase; and (vi) nucleotides, sequentially thermally cycling the temperature of the nucleic acid solution in each reaction chamber between a denaturing state, an annealing state, and an extension state for a predetermined number of cycles at heating and a cooling rates of about 4 ĀØ 150 C/sec, to yield 5 or more amplified loci in each reaction chamber.
In a seventh aspect, the invention provides integrated biochips systems comprising a biochip comprising at least two reaction chambers in microfludic communication, wherein a first reaction chamber is in thermal communication with a thermal cycler, comprising: a.
temperature control element (TCE) wherein a first surface of the TCE is adapted to receive a substrate containing a sample, and a thermosensor positioned to measure the temperature of sample in the substrate and provide feedback to the TCE to set or maintain the sample at a desired temperature wherein a contact surface of the biochip is in thermal communication with the first surface of the thermal cycler; and a second reaction chamber in fluid connection with the first reaction chamber and adapted for nucleic acid extraction, nucleic acid purification, pre-PCR nucleic acid cleanup, post-PCR cleanup, pre-sequencing cleanup, sequencing, post-sequencing cleanup, nucleic acid separation, nucleic acid detection, reverse transcription, pre-reverse transcription cleanup, post-reverse transcription cleanup, nucleic acid ligation, nucleic acid hybridization, or quantification, wherein the first reaction chamber is less than 200 Am from a contact surface of the biochip.
Specific preferred embodiments of the present invention will become evident from the following more detailed description of certain preferred embodiments and the claims.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure IA is a photograph of an embodiment of the thermal cycler of the invention.

Figure 1B is a photograph showing an embodiment of a 16-lane microfluidic biochip for use with the thermal cycler shown in Figure 1A.
Figure 2A is a graph showing the temperature profiles of block and reaction solution for one thermal cycle of the standard STR cycling protocol described herein (total cycling time: 145.1 minutes).
Figure 2B is a graph showing the temperature profiles of block and reaction solution for one thermal cycle of the fast cycling protocol described herein (total cycling time: 19.56 minutes).
Figure 3 is a graph showing temperature profiles of the heat pump and the reaction solution for one thermal cycle for a thermal cycler of the invention using fast cycling conditions (total cycling time: 17.3 minutes).
Figure 4A is a graph showing the STR profile generated in biochip reactions according to the invention using 0.5 ng template DNA.
Figure 4B is a graph showing the STR profile generated in tube reactions according to the invention using 0.5 ng template DNA.
Figure 5A is a graph showing the effect of DNA template level on signal strength in biochip reactions.
Figure 5B is a graph showing the effect of DNA template level on signal strength in tube reactions.
Figure 6A is a graph showing the effect of DNA template level on heterozygous peak height ratio (PHR) in biochip reactions.
Figure 6B is a graph showing the effect of DNA template level on PHR in tube reactions.
Figure 7A is a graph showing the effect of DNA template level on non-template nucleotide addition (NTA) in biochip reactions.
Figure 7B is a graph showing the effect of DNA template level on NTA in tube reactions Figure 8A is a graph showing the effect of DNA template level on stutter in biochip reactions.
Figure 8B is a graph showing the effect of DNA template level on stutter in tube reactions Figure 9A is a graph showing the profile for biochip (top) and tube reaction (bottom) generated with the COfilerTm primer set using lng template DNA.
7 Figure 9B is a graph showing the profile for biochip (top) and tube reaction (bottom) generated with the IdentifilerTm primer set using lng template DNA.
Figure 10 is a graph showing the profile for an embodiment of a sequencing reaction, as described in Example 5, DETAILED DESCRIPTION OF THE INVENTION
In order to achieve fast multiplexed nucleic acid amplification, such as PCR, the invention provides thermal cycling instrumentation, reaction vessels, and reaction conditions that can be used to amplify a plurality of loci within a target nucleic acid sample. As is illustrated by the examples provided herein, fast thermal cycling methods of the invention can be performed in microfluidic biochips using the thermal cycler of the invention and the methods described herein.
The methods provided by the invention are capable of rapid multiplex amplification in applications in addition to those utilizing the biochips and thermal cyclers described herein.
For example, the use of thin walled tubes in conventional thermal cyclers (for example block based thermal cyclers and the Roche LightCyclerTm) and the use of amplification methods other than temperature cycled PCR (for example isothermal PCR or rolling circle amplification) are specifically contemplated.
The methods, biochips, and thermal cyclers provided by the invention are capable of amplifying a plurality of loci in under 100 minutes within a given nucleic acid solution present at amounts of at least 0.006 ng of human genomic DNA (the approximate amount of DNA in a single nucleated human cell) containing the target nucleic acid locus or loci). In other embodiments the amplification occurs in less than 90 min., less than 80 min., less than 70 min., less than 60 min., less than 50 min., less than 40 min., less than 30 min., less than 20 min., less that 17.7 min., less than 15 min., less than 10 min., or less than 5 min..
In other embodiments, a plurality of loci within a bacterial, viral, fungal, animal, or plant-derived genome can be amplified starting from at least one copy of the target nucleic acid locus or loci. For example, a sample to be analyzed can comprise less than 1000 copies, less than 400 copies, less than 200 copies, less than 100 copies, less than 50 copies, less than 30 copies, less than 10 copies or at least 1 copy of a target nucleic acid prior to the multiplexed amplification reaction. In addition, less than a single genome equivalent of DNA
can be utilized for amplification if the target nucleic acid locus is present in more than one copy in the genome. Generally, at least two loci, and up to approximately 250 loci can be
8 simultaneously amplified within each target nucleic acid in a sample according to the methods described herein. Further, at least two loci and up to approximately 250 loci can be simultaneously amplified in a plurality of target nucleic acids according to the methods described herein.
The target nucleic acids utilized herein can be any nucleic acid, for example, human nucleic acids, bacterial nucleic acids, or viral nucleic acids. The target nucleic acid sample can be, for example, a nucleic acid sample from one or more cells, tissues, or bodily fluids such as blood, urine, semen, lymphatic fluid, cerebrospinal fluid, or amniotic fluid, or other biological samples, such as tissue culture cells, buccal swabs, mouthwashes, stool, tissues slices, biopsy aspiration, and archeological samples such as bone or mummified tissue.
Target nucleic acids can be, for example, DNA, RNA, or the DNA product of RNA
subjected to reverse transcription. Target samples can be derived from any source including, but not limited to, eukaryotes, plants, animals, vertebrates, fish, mammals, humans, non-humans, bacteria, microbes, viruses, biological sources, serum, plasma, blood, urine, semen, lymphatic fluid, cerebrospinal fluid, amniotic fluid, biopsies, needle aspiration biopsies, cancers, tumors, tissues, cells, cell lysates, crude cell lysates, tissue lysates, tissue culture cells, buccal swabs, mouthwashes, stool, mummified tissue, forensic sources, autopsies, archeological sources, infections, nosocomial infections, production sources, drug preparations, biological molecule productions, protein preparations, lipid preparations, carbohydrate preparations, inanimate objects, air, soil, sap, metal, fossils, excavated materials, and/or other terrestrial or extra-terrestrial materials and sources. The sample may also contain mixtures of material from one source or different sources. For example, nucleic acids of an infecting bacterium or virus can be amplified along with human nucleic acids when nucleic acids from such infected cells or tissues are amplified using the disclosed methods. Types of useful target samples include eukaryotic samples, plant samples, animal samples, vertebrate samples, fish samples, mammalian samples, human samples, non-human samples, bacterial samples, microbial samples, viral samples, biological samples, serum samples, plasma samples, blood samples, urine samples, semen samples, lymphatic fluid samples, cerebrospinal fluid samples, amniotic fluid samples, biopsy samples, needle aspiration biopsy samples, cancer samples, tumor samples, tissue samples, cell samples, cell lysate samples, crude cell lysate samples, tissue lysate samples, tissue culture cell samples, buccal swab samples, mouthwash samples, stool samples, mummified tissue samples, autopsy samples, archeological samples, infection samples, nosocomial infection samples, production samples, drug preparation samples,
9 biological molecule production samples, protein preparation samples, lipid preparation samples, carbohydrate preparation samples, inanimate object samples, air samples, soil samples, sap samples, metal samples, fossil samples, excavated material samples, and/or other terrestrial or extra-terrestrial samples. Types of forensics samples include blood, dried blood, bloodstains, buccal swabs, fingerprints, touch samples (e.g., epithelial cells left on the lip of a drinking glass, the inner rim of a baseball cap, or cigarette butts), chewing gum, gastric contents, saliva, nail scrapings, soil, sexual assault samples, hair, bone, skin, and solid tissue. Types of environmental samples include unfiltered and filtered air and water, soil, swab samples from surfaces, envelopes, and powders.
For example, the methods herein can provide amplified nucleic acid samples whose analysis yields data suitable for forensic interpretation, and in particular, data that satisfies forensic interpretation guidelines. Such guidelines include signal strength, inter-loci peak height balance, heterozygous peak height ratio (PHR), incomplete non-template nucleotide addition (NTA), and stutter (Scientific Working Group on DNA Analysis Methods, Short Tandem Repeat (STR) Interpretation Guidelines. Forensic Science Communications, 2000, 2(3)).
The phrase "fluid communication" as used herein, refers to two chambers, or other components or regions containing a fluid, connected together so that a fluid can flow between the two chambers, components, or regions. Therefore, two chambers that are in "fluid communication" can, for example, be connected together by a microfluidic channel between the two chambers, such that a fluid can flow freely between the two chambers.
Such microfluidic channels can optionally include one or more valves therein which can be closed or occluded, in order to block and/or otherwise control fluid communication between the chambers.
The term "poly(methyl methacrylate) or "PlVIMA," as used herein, means the synthetic polymers of methyl methacrylate, including but not limited to, those sold under the tradenames Plexiglas, Limacryirm, R-Cast, Perspex', Plazcrylrm, Acrylex TM, ACrylitemi, ACrylplastml, AltuglasTm, PolycastTm and Lucite, as well as those polymers described in US Patent Nos. 5,561,208, 5,462,995, and 5,334,424.
The term "polycarbonate" as used herein means a polyester of carbonic acid and glycol or a divalent phenol. Examples of such glycols or divalent phenols are p-xylyene glycol, 2,2-bis(4-oxyphenyl)propane, bis(4-oxyphenyl)methane, 1,1-bis(4-oxyphenyl)ethane, 1,1-bis(oxyphenyl)butane, 1,1-bis(oxyphenyl)cyclohexane, 2,2-bis(oxyphenyl)butane, and mixtures thereof, including but not limited to, those sold under the tradenames Calibre', MalcrolonTm, PanliteTm, MalcroclearTm, CyrolonTM, LexanTm and Tuffak TM.
As used herein the term "nucleic acid" is intended to encompass single- and double-stranded DNA and RNA, as well as any and all forms of alternative nucleic acid containing modified bases, sugars, and backbones. The term "nucleic acid" thus will be understood to include, but not be limited to, single- or double-stranded DNA
or RNA (and forms thereof that can be partially single-stranded or partially double-stranded), cDNA, aptamers, peptide nucleic acids ("PNA"), 2'-5' DNA (a synthetic material with a shortened backbone that has a base-spacing that matches the A conformation of DNA; 2'-5' DNA will not normally hybridize with DNA in the B form, but it will hybridize readily with RNA), and locked nucleic acids ("LNA"). Nucleic acid analogues include known analogues of natural nucleotides that have similar or improved binding, hybridization of base-pairing properties.
"Analogous" forms of purines and pyrimidines are well known in the art, and include, but are not limited to aziridinylcytosine, 4-acetylcytosine, 5-fluorouracil, 5-bromouracil, 5-carboxymethylaminomethy1-2-thiouracil, 5-carboxymethylaminomethyluracil, inosine, N6-isopentenyladenine, 1-methyladenine, 1-methylpseudouracil, 1-methylguanine, 1-methylinosine, 2,2-dimethylguanine, 2-methyladenine, 2-methylguanine, 3-methylcytosine, 5-methylcytosine, N6-methyladenine, 7-methylguanine, 5-methylaminomethyluracil, 5-methoxyaminomethy1-2-thiouracil, beta-D-mannosylqueosine, 5-methoxyuracil, 2-methylthio-N-6-isopentenyladenine, uracil-5-oxyacetic acid methylester, pseudouracil, queosine, 2-thiocytosine, 5-methyl-2-thiouracil, 2-thiouracil, 4-thiouracil, 5-methyluracil, uracil-5-oxyacetic acid, and 2,6-diaminopurine. DNA backbone analogues provided by the invention include phosphodiester, phosphorothioate, phosphorodithioate, methylphosphonate, phosphoramidate, alkyl phosphotriester, sulfamate, 3'-thioacetal, methylene(methylimino), 3'-N-carbamate, morpholino carbamate, and peptide nucleic acids (PNAs), methylphosphonate linkages or alternating methylphosphonate and phosphodiester linkages (Strauss-Soukup, 1997, Biochemistry 36:8692-8698), and benzylphosphonate linkages, as discussed in US 6,664,057; see also OLIGONUCLEOTIDES AND ANALOGUES, A
PRACTICAL
APPROACH, edited by F. Eckstein, IRL Press at Oxford University Press (1991);
Antisense Strategies, Annals of the New York Academy of Sciences, Volume 600, Eds.
Baserga and Denhardt (NYAS 1992); Milligan, 1993, J. Med. Chem. 36:1923-1937; Antisense Research and Applications (1993, CRC Press). The nucleic acids herein can be extracted from cells or synthetically prepared according to any means known to those skilled in the art; for example, the nucleic acids can be chemically synthesized or transcribed or reverse transcribed from cDNA or mRNA, among other sources.
The term "via" as used herein means a through-hole formed in a solid material to allow fluidic connection between the top and bottom surfaces of the material.
The terms "locus" and "loci" (plural) as used herein mean one or more specific positions on one or more nucleic acids (e.g., one or more chromosomes), as defined herein.
The terms "STR locus" and "STR loci" as used herein means a nucleotide sequence consisting of a repeating pattern of two or more nucleotides at a given locus of a target nucleic acid. The repeating pattern can range in length from 2 to 10 base pairs (bp), and is typically in the non-coding intron region.
According to one aspect of the invention, a thermal cycler is provided having the capability of heating and cooling a reaction solution rapidly, controllably, and reproducibly.
An example of an embodiment of the thermal cycler of the invention is shown in Figure 1A.
The ability to rapidly heat and cool the reaction solution temperatures allows ramping and settling times to be minimized and incubation time at the desired temperature to dominate the total step time, enabling minimization of multiplex cycling times.
High heating and cooling rates can be achieved by utilizing a temperature control element (TCE), either alone or in fluid communication with a heat sink. A TCE
comprises a means for heating and cooling, a thermosensor, a controller that receives signals from the thermosensor, and a power supply. In a preferred embodiment, a first surface of the TCE
can be adapted to receive a sample chamber containing a solution and a sensing chamber containing an additional thermosensor. In this setting, the thermosensor is positioned within the sensing chamber mounted to the TCE such that it simulates the conditions within the sample chamber. This sensing chamber is fabricated such that it has the same material stack-up as the sample chamber. A thermocouple mounted within the temperature sensor is embedded in the structure at an analogous position to that of the sample in the sample chamber. This sensor reports the effective temperature of the solutions in the sample chamber. Commercially-available Type-T or Type-K thermocouples (from Omega Engineering, Stamford, CT) are most applicable but other types of thermocouple and thermosensor may be used including thermisters, semiconductors, and infrared.
The thermosensor within the sensing chamber provides feedback to the TCE to set or maintain the sample at the desired temperature. In this way, the sample temperature can be measured indirectly and controlled without inserting a thermosensor into the reaction chamber itself.
Alternatively, a thermosensor can be placed directly into the reaction chamber and used to set and maintain sample temperature, eliminating the need for the sensing chamber.
As one skilled in the art will appreciate, other types of sensors such as pressure sensors may be utilized according to the teachings of this invention.
The first surface of the TCE can be adapted to accept an essentially flat substrate by, for example, forming a recess in the first surface for accepting a substrate (e.g., a biochip, infra). Alternatively, the TCE can be adapted to accept one or more thin-walled tubes, defined as tubes with wall diameters with regions less than 200 1.1M thick.
Preferably, the heat sink is a high efficiency heat sink, such as, but not limited to, fan-cooled heat sinks with copper bases and cooling fins. More preferably, the heat sink can be a fan cooled copper base and fins having a thermal resistance of about 0.4 C/W or less. A
particular and non-limiting example of a high efficiency heat sink is E1U-N7BCC-03-GP
(Coolermaster, Taiwan ROC).
The thermal cycler of the invention may further comprise a thermosensor positioned to monitor the temperature of the first surface of the TCE. Additional thermosensors can be added as desired to achieve further improvement in sample temperature control.
The supplementary temperatures that can be monitored include those on multiple regions on and within the substrate, multiple regions on and within the heat sink, cooling air input and output, sample input and output, and ambient.
Good thermal communication between the TCE and the heat sink is desired. When the two mating surfaces are properly prepared, intimate physical contact is sufficient to provide adequate thermal transfer between the two components. Thermal interface materials (TIMs) between the TCE and heat sink can be used to enhance thermal coupling.
Such TIIVIs include but are not limited to adhesives, greases, phase-change materials (PCMs), metal thermal interface materials, ceramic thermal interface materials, soft metal alloys, indium, alumina nano-layer coatings, submicron films, glycol, water, oils, antifreeze, epoxy compounds, and others. Specific examples include Arctic Silver or Ceramique (Arctic Silver, Visalia, CA; compounds that have thermal resistances of < 0.007 C-in2/W), compressible heat spring HSD4 (Indium Corp, Utica, NY), HITIIERM (GrafTech International Holdings Inc., Lakewood, OH), or directly bonding of the TCE to the surface of the heat sink. Thermal contact can be further enhanced by physical clamping the components together with a average force of more than 2 psi, or more than 5 psi, or more than 10 psi, or more than 30 psi, or more than 60 psi or more than 100 psi or more than 200 psi, or by direct bonding of the surfaces.
Thermal transfer between the TCE and a substrate in contact therewith can be increased with respect to block thermal cyclers, such as the Eppendorf MastercyclerTm ep gradient S thermal cycler (which provide heat energy via a silver block with high thermal conductivity and low specific heat capacity), by placing the substrate directly on the TCE.
Suitable TCEs include, but are not limited to, a high heating and cooling capacity heat pump, and high power output Peltier devices; examples of Peltier devices are (Ferrotec, Bedford NH), XLT2393 (Marlow, Dallas TX). When utilized as a part of the TCE
for thermal cyclers of the invention, Peltier devices are advantageously powered by an H-bridge. An example of an H-bridge device is the 5R7-001 (Oven Industries).
When Peltier devices are used as a part of the TCE for thermal cyclers of the invention, it is advantageous to power the Peltier devices by an H-bridge with pulse width modulation for heating and cooling. Temperature feedback from the thermosensor which measures the sample temperature drives the TCE to set and maintain the desired sample temperature. Closed-loop temperature control algorithms for control of the TCE
include, but are not limited to, PID control and fuzzy logic control.
Said thermal controllers comprise a control algorithm that provides the capacity for rapid transition from one target temperature state to another target temperature state. This transition can be divided into 3 distinct phases. In phase 1, there is a large difference between the actual temperature and target temperature (for example 1 to 20 C or higher). In this phase, ramping takes place at or near the maximum rate of the TCE device. In phase 2, the transition phase, the actual temperature and target temperature are closer (less than approximately 1 to 20 C). In this case the controller must reduce the power to the TCE in order to prevent overshoot of the solution temperature and allow for rapid achievement of target temperature with minimal deviations and oscillations. In phase 3, the target temperature has been achieved and the controller moderates power to the thermal cycler to maintain the solution within a narrow range about the target temperature.
Measurement of the temperature with the sensor provides more accurate feedback of the actual temperature and also allows the temperature of the TCE surface temperature to be overdriven.
Each of the above 3 phases may be further subdivided into multiple sub-phases to provide for faster response time, more accurate temperature control, increased stability, and increased tolerance to external variability.
In one example, the temperature of the substrate can be measured by placing a thin thermocouple into a channel on the substrate surface. In another example, the second thermosensor can be housed in an enclosure, formed from essentially the same material as the substrate being utilized, that holds the second thermosensor essentially the same distance from the TCE as a reaction chamber on a substrate in contact with the TCE.
Such a second thermosensor can generally be separate from the substrate (i.e., a stand-alone sensor), and can be placed next to the substrate on the first surface of the TCE.
The heat sink may, optionally, further comprise a variable speed cooling fan and/or a second heating element for controlling the temperature of the heat sink, where each additional element of the heat sink is in communication with the second control element.
This allows the cooling efficiency of the heat sink to be adjusted, in particular to keep the heat sink temperature essentially constant and independent of environmental temperature changes. The heater can also precondition the heat sink to essentially the operating temperature.
To facilitate thermal coupling of a reaction solution in a substrate and the TCE, uniform thermal communication of a contact surface of the substrate with the first surface of the TCE can be provided by applying a force to the substrate to secure it thereto while the thermal cycler is in operation. Such forces are preferably applied by means that only temporarily hold the substrate to the first surface of the TCE and can be readily removed upon completion of thermal cycling. For example, a chip compression element (CCE) can be situated above the first surface of the TCE to allow the substrate to be placed between. The chip compression element can then be engaged to hold the substrate in place during operation of the thermal cycler, and released to allow removal of the substrate. Proper integration of the CCE, TCE and heat sink allows the CCE to improve thermal coupling between and among all three of these components.
The portion of the CCE in contact with a substrate can be formed from a low thermal mass insulating material, including, but not limited to, a foam, for example WF71 Rohcell foam (Inspec foams, Magnolia, AR). For embodiments discussed herein the Rohacell is preferred. It has a specific heat capacity of 1.4-1.6 (J/gK) [or less thermal mass] and a thermal conductivity of 0.0345 W/mK (or less).
Biochip compression elements include, but are not limited to, one or more clamps, springs, compressible foam, or a pressurized air bladder which can be inflated to provide force to hold the substrate onto the first surface of the TCE. Preferably, the chip compression element provides a substantially uniform force of about 5 to about 250 psia to a surface of the substrate, and more preferably, about 20 to about 50 psia to hold the substrate to the first surface of the TCE. Notably, thermal communication between the contact surface of the biochip substrate and the TCE can be provided in the absence of a thermal coupling solutions such as thermal grease or glycol, although such can be utilized as necessary.
The biochip compression elements provide a force on the biochip-thermoelectric cooler-heat sink. This force serves to ensure good thermal contact and hence heat transfer between the biochip and the top surface of the TCE.
In one embodiment, the low thermal mass insulator is an air bladder and is utilized to provide the low thermal mass and insulating properties. In another embodiment, the low thermal mass insulator is a foam pad. The clamping force can be applied to the foam pad by a pneumatic cylinder, or closed cell foam pads under compression or air pressure from an air bladder. In the latter case, the air bladder provides both the insulation and the compressive force.
As described above, the thermal cycler can have a heating and/or cooling rate at the first surface of the TCE surface about 4 ĀØ 150 C per second, and preferably about 8 ĀØ 150 C/sec, and more preferably about 10 ĀØ 150 C/sec. The thermal cycler can also have a heating or cooling rate at a solution within a reaction chamber of a substrate in uniform thermal communication with the first surface of the TCE (e.g., a biochip) of about 4 ĀØ 150 C
per second and preferably about 8 ĀØ 150 C/sec, and more preferably about 10 ĀØ
150 C/sec.
Further, the thermal cycler of the invention can have a temperature stability of +/- 1.0 C, and preferably +/- 0.50 C, and more preferably +/- 0.25 C.
Biochip, An embodiment of a biochip (i.e., a substrate for use with the thermal cycler of the invention) according to another aspect of the invention is shown for the sake of illustration in Figure 1B as having 16 microfluidic systems, each comprising an inlet and an outlet in fluid communication with each of the reaction chambers formed within the biochip.
However, such disclosure is not intended to be limiting, rather, one skilled in the art will readily recognize that the biochip can contain alternate numbers of microfluidic systems (infra) including biochips with one system and biochips with two or more systems. The term "plurality" as used herein, means two or more, four or more, eight or more, 16 or more, 32 or more, 48 or more, 64 or more, 96 or more, 128 or more, or 2 ĀØ 16, 2 ĀØ 32, 2 ĀØ
48, 2 ĀØ 64, 2 ĀØ
96, 2 ĀØ 128, 8 ĀØ 128, 8 - 64, or 8 ĀØ 32 microfluidic channels.

The biochip can comprise a substrate layer and a cover layer, where a portion of one or a plurality of microfluidic systems, comprising grooves and/or shaped depressions, are patterned into the substrate layer. A series of vias (i.e., through holes and/or inlets or outlets) can be formed in the cover layer to provide fluidic access to the microfluidic channels and reaction chambers, and can be located at any location about the biochip.
Alternatively, vias can be formed in the substrate layer instead of the cover layer to achieve the same functionality. The top surface of the substrate layer can be bonded with the bottom surface of the cover layer to complete the microfluidic systems. Techniques for fabricating polymer-based microfluidic systems are reviewed extensively by Becker and Gartner (Becker, 2000, Electrophoresis 21, 12-26 and Becker, 2008, Electrophoresis 390, 89).
Biochips can be fabricated using materials such as unsaturated, partially unsaturated or saturated cyclic olefin copolymers "COC ", unsaturated, partially unsaturated, or saturated cyclic olefin polymers "COP", poly(methyl) methacrylate "PMMA", polycarbonate "PC", polypropylene "PP", polyethylene "PE", polyetheretherketone "PEEK", poly(dimethylsiloxane) "PDMA", polyimide "P1". It is important to select a plastic with a glass transition temperature greater than that of the maximal temperature to be utilized in the amplification reaction. Any number of these processes and materials can be used to fabricate the biochips described herein. In particular, the biochips can be prepared by injection molding of a plastic substrate, for example, a COC
or COP based polymers (currently sold under the tradenames TopasTm, ZeonexTm, ZeonorTM, and ApelTm). In this fabrication methodology, an injection mold and mold insert consisting of the negative of the features to be formed is fabricated by machining and subsequent surface polishing. Together, the mold and insert allow the substrate layers to be fabricated and the formed substrate to comprise the channels, reaction chamber features and vias.
The substrate and cover layers can be diffusion bonded by the application of heat and pressure.
Altematively, the biochips can be prepared by hot embossing of thin thermoplastic films with a master die of the negative of the structure to be produced. The mastcr die can bc prepared by using electroforming to replicate the device prepared in a solid substrate. The solid substrate can be glass sheets that are patterned by standard photolithographic and chemical etching methods known to those skilled in the art. The substrate and cover layers are diffusion bonded by the application of heat and pressure.
The substrate and cover layers of the biochip can be constructed from a variety of plastic substrates including, but not limited to, polyethylene, poly(acrylates) (e.g., poly(methyl methacrylate)), poly(carbonate)s, and unsaturated, partially unsaturated or saturated cyclic olefin polymers (COP), or an unsaturated, partially unsaturated, or saturated cyclic olefin copolymers (COC). The thickness of plastic substrate and cover layers utilized in the present process is kept thin to minimize the mass thereof to thereby maximize thermal transfer between the thermal cycler and the reaction solution contained in each reaction chamber during their use. The plastic substrate and cover layers can each, independently, have a thickness of less than 2 mm, less than 1 mm, less than 750 pm, less than 650 pm, less than 500 Am, less than 400 pm, less than 300 p.m, less than 200 Am, or less than 100 pm; or plastic substrate and cover layers can each, independently, comprise a plastic having a thickness ranging from 25 ĀØ 2000 pm, 25 ĀØ 1000, 25 ĀØ 750 pm, 25 ĀØ 650 mm, 25 ĀØ
500 p.m, 25 ĀØ 400 p.m, 25 ĀØ 300 pm, 25 ĀØ 200 pm, or 25 ĀØ 100 pm. Preferably, at least one of the substrate and cover layers has a thickness of less than about 200 pm to maximize thermal transfer to the reaction solution contained in the reaction chambers of the biochip. More preferably, a contact surface of the biochip which is in contact with the first surface of the TCE has a thickness of less than about 200 pm.
Each reaction chamber can be formed to have a volume of, for example, less than 100 AL. Preferably, each reaction chamber has a volume of less than about 50 AL, or less than about 40 AL, or less than about 30 AL, or less than about 25 AL, or less than about 20 pL, or less than about 15 AL, or less than about 10 AL, or less than about 5 AL or less than about 1 AL, or less than about 0.1 AL. Alternatively, each reaction chamber can be formed to have a volume ranging from about 0.1 AL to about 100 AL. Preferably, each reaction chamber has a volume ranging from about 0.1 AL to about 10 AL or about 10 AL to about 50 AL.
The reaction chambers are generally not coated with a polymer or silane coating.
Reaction chambers may be designed to have an inlet and an outlet channel.
Alternatively, a single channel may be used for inlet and outlet.
The biochip design of the invention leverages the benefits of microfluidics including having a high surface to volume ratio and reduced diffusion times to maximize heat transfer, and uniform heating and cooling. The use of microfluidic technology also provides benefits with respect to a fully-integrated forensic analysis instrument. Further, biochips fabricated by diffusion bonding, and without the use of adhesives to bond the various layers (e.g. COC
layers), were tested and demonstrated to be capable of withstanding from 100 to 1500 psi of pressure before failure based on the requirements of the desired application.
For example, the biochips of the present invention withstand 450 psi, sufficient for the desired thermal cycling applications.
It is noted that the specific embodiments of the biochips of the invention set forth herein substantially lack any heating elements integrated into the biochip for heating and/or cooling the reaction chambers. Thermal cycling of the reaction chambers on the biochip is provided externally, for example, by the thermal cycler of the invention.
Heating elements can be integrated into the biochips of the present invention, however.
In operation, one portion of the biochip can receive one or more reaction solutions, each independently comprising one or more reagents (e.g., for PCR) and or nucleic acid samples, through one or more inlets in fluid communication with one or more reaction chambers formed within the biochip. Simultaneous amplification of a plurality of samples can be performed by injecting each of the nucleic acid samples in a separate separation reaction chamber. An injector for simultaneously injecting a plurality samples into the plurality of sample or buffer wells can be provided with the biochip to enable simultaneous multiple sample amplification. Such injectors provide, for example, one sample of the plurality of samples to one reaction chamber of the plurality of reaction chambers. Injectors can introduce the samples to the channels according to any methods known to those skilled in the art, for example, by electrophoretic transport, pneumatic actuation or liquid actuation through a needle or tube or channel that connects the sample to the reaction chamber.
Following amplification (and optionally, nucleic acid extraction and quantification) the amplified nucleic acid product can be passed (e.g., to a Genebench-Fkrm 100) through one or more outlets in fluid communication with the reaction chambers for fragment separation and generation of STR profiles.
The relatively low cost of plastic manufacture allows the biochips of the invention to be disposable, eliminating the labor required to reuse the biochip and essentially eliminating the possibility of contamination. A single-use disposable would be particularly advantageous for low copy number analyses in that no possibility of contamination (other than initial sample collection) would exist. In settings where neither contamination nor labor are major considerations, reusable plastic and glass biochips may be utilized.
Integration Methods Using microfluidics allows fabrication of features to perform more than one function on a single biochip. These functions can include nucleic acid extraction, nucleic acid purification, pre-PCR nucleic acid cleanup, post-PCR cleanup, pre-sequencing cleanup, sequencing, post-sequencing cleanup, nucleic acid separation, nucleic acid detection, reverse transcription, pre-reverse transcription cleanup, post-reverse transcription cleanup, nucleic acid ligation, nucleic acid hybridization and quantification. Two or more of these functions can be connected microfluidically to enable sequential processing of a sample;
this coupling is termed integration.
One form of microfluidic DNA extraction can be achieved by inserting a purification medium between an input and output channel. This purification medium can be silica fiber based and use chaotropic-salt reagents to lyse the biological sample, expose the DNA and bind the DNA to the purification media. The lysate is then transported via the input channel through the purification medium to bind the DNA. Bound DNA is washed by an ethanol based buffer to remove contaminants. This can be accomplished by flowing wash reagents via the input channel through the purification membrane. Bound DNA is then eluted from the membrane by flowing an appropriate low salt buffer (see, e.g., Boom, US
5,234,809) via the input channel through the purification membrane and out the output channel.
One approach to DNA quantification in a microfluidic format is based upon real-time PCR. In this method of quantification, a reaction chamber is fabricated between an input and output channel. The reaction chamber is coupled to a thermal cycler and an optical excitation and detection system is coupled to the reaction chamber to allow fluorescence from the reaction solution to be measured. The amount of DNA in the sample is correlated to the intensity of the fluorescence from the reaction chamber per cycle (see, e.g., Heid et al., Genotne Research 1996, 6, 986-994).
For further information about integration in microfluidic formats, see the U.S. Patent application entitled "INTEGRATED NUCLEIC ACID ANALYSIS" filed on even day herewith (Attorney Docket No. 07-801-US).
For further information about separation and detection in microfluidic formats see the U.S.
Patent application entitled "Plastic Microfluidic Separation and Detection Platforms" filed on even day herewith (Attorney Docket No. 07-865-US).
Microfluidic drives of the invention are means for transporting fluids within the reaction chambers of the integrated biochips. One type of microfluidic drive is effected by incorporated a membrane pump which transports the fluid by sequential application of positive and negative pressure to the membrane. Alternatively, a positive displacement pump can be connected to the input of the microfluidic chamber. A displacement of the pump forces the fluid through the microfluidic channel.

Integration can make use of microfluidic valves to gate fluid flow within the biochip.
Valving can be accomplished with passive or active structures. Passive valving structures include capillary valves that stop fluid flow by utilizing capillary pressure.
Fluids can flow through the capillary valving structure by the application of a pressure that is sufficiently large enough to overcome the capillary forces. Active valving structures include membrane valves which use flexible or semi-rigid structures at a point between two channels. The application of pressure on the membrane causes it to close the channel. The application of a vacuum to the membrane lifts it from the channel, allowing passage of fluids.
Amplification Methods In yet another aspect, the invention provides methods for simultaneously amplifying a plurality of nucleic acid loci in one or more target nucleic acids via rapid polymerase chain reaction (PCR). Such methods comprise providing one or a plurality of reaction solutions to one or a plurality of reaction chambers, wherein each reaction solution comprises (i) at least one copy of at least one target nucleic acid, wherein each target nucleic acid is the same or different and each target nucleic acid independently comprises a plurality loci to be amplified; (ii) one or more buffers; (iii) one or more salts; (iv) a primer set corresponding to the plurality of loci to be amplified; (v) a nucleic acid polymerase; and (vi) nucleotides. Each of the reaction solutions, for example, each of the target nucleic acids, can be the same or different as necessary, for example, to run multiple simultaneous analyses on the same nucleic acid sample, or to simultaneously run multiple nucleic acid samples.
Each reaction chamber may be contained within a biochip of the invention as described above or thin-walled reaction tubes. Thin-walled reaction tubes preferably have a wall thickness of less than about 200 Am. Preferably, thin-walled reaction tubes preferably have a wall thickness of less than about 100 ttm.
Primers for PCR amplification are oligonucleotide sequences that are specifically designed to hybridize to loci of the target DNA. These primers serve as starting points for polymerase extensions. To facilitate analysis of amplified fragments, labeled primers can also be used in PCR reactions. Labeled primers are oligonucleotide sequences that are coupled to a detectable moiety; a non-limiting example thereof is a fluorescent dye. When PCR is carried out with fluorescently labeled primers, amplicons with a fluorescent label are generated. The methods for performing fast PCR are compatible with both labeled and unlabeled primers, and fast multiplexed PCR have been demonstrated.

Primer sets can be any known to those skilled in the art for the amplification of a plurality of loci with a target nucleic acid, as described above. For example, primers useful in amplification of one or more loci in a human nucleic acid sample are described in US5,582,989; US5,843,660; US6,221,598; US6,479,235; US6,531,282; and US7,008,771;
and US Patent Application Publication Nos. 2003/0180724; 2003/0186272; and 2004/0137504.
Further, primers useful in amplification of one or more loci in a viral nucleic acid sample are described in, for example, US7,312,036; US6,958,210; US6,849,407;
US6,790,952, and US6,472,155 .
Examples of primers useful in amplification of one or more loci in a bacterial nucleic acid sample are described in US7,326,779; US7,205,111; US7,074,599;
US7,074,598;
US6,664,080; and US5,994,066.
Salts and buffers include those familiar to those skilled in the art, including those comprising MgC12, and Tris-HC1 and KC1, respectfully. Buffers may contain additives such as surfactants (e.g., Tweens), dimethyl sulfoxide (DMSO), glycerol, bovine serum albumin (BSA) and polyethylene glycol (PEG), as well as others familiar to those skilled in the art.
Nucleotides are generally deoxyribonucleoside triphosphates, such as deoxyadenosine triphosphate (dATP), deoxycytidine triphophate (dCTP), deoxyguanosine triphosphate (dGTP) and deoxythymidine triphosphate (dTTP) are also added to the synthesis mixture in adequate amount for amplification of the target nucleic acid.
The solutions can be optionally heated to and held at a first temperature for a first period of time suitable for hot-start activation of the nucleic acid polymerases. Generally, the first period of time is less than about 90 seconds. The first temperature can be about 95 to about 99 C. Polymerases with hot start mechanisms that can be activated in 60 seconds or less include those utilizing antibody mediated hot-start and aptmer mediated hot start mechanisms. Alternatively, hot-start polymerases need not be utilized in the present invention.
Subsequently, the temperature of the reaction solutions are sequentially cycled between a denaturing state, an annealing state, and an extension state for a predetermined number of cycles. Generally, the one or a plurality of reaction solutions are cooled from the denaturing state to the =leafing state at a first cooling rate of about 1 to about 150 C/sec, or about 1 to about 100 C/sec; or about 1 to about 80 C/sec; or about 1 to about 60 C/sec; or about 1 to about 40 C/sec; or about 1 to about 30 C/sec; or about 1 to about 20 C/sec;
about 4 to about 150 C/sec, or about 4 to about 100 C/sec; or about 4 to about 80 C/sec; or about 4 to about 60 C/sec; or about 4 to about 40 C/sec; or about 4 to about 30 C/sec; or about 4 to about 20 C/sec; or about 10 to about 150 C/sec; or about 10 to about 100 C/sec;
or about 10 to about 80 C/sec; or about 10 to about 60 C/sec; of about 10 to about 40 C/sec; or about 10 to about 30 C/sec; or about 10 to about 20 C/sec. The one or a plurality of reaction solutions can be heated from the annealing state to the extension state at a first heating rate of about 1 to about 150 C/sec, or about 1 to about 100 C/sec;
or about 1 to about 80 C/sec; or about 1 to about 60 C/sec; or about 1 to about 40 C/sec;
about 1 to about 30 C/sec; about 1 to about 20 C/sec; 4 to about 150 C/sec, or about 4 to about 100 C/sec; or about 4 to about 80 C/sec; or about 4 to about 60 C/sec; or about 4 to about 40 C/sec; about 4 to about 30 C/sec; about 4 to about 20 C/sec; or about 10 to about 150 C/sec; or about 10 to about 100 C/sec; or about 10 to about 80 C/sec; or about 10 to about 60 C/sec; of about 10 to about 40 C/sec; or about 10 to about 30 C/sec; or about 10 to about 20 C/sec; and/or the one or a plurality of reaction solutions are heated from the extension state to the denaturing state at a second heating rate of about 1 to about 150 C/sec, or about 1 to about 100 C/sec; or about 1 to about 80 C/sec; or about 1 to about 60 C/sec;
or about 1 to about 40 C/sec; about 1 to about 30 C/sec; about 1 to about 20 C/sec; about 4 to about 150 C/sec, or about 4 to about 100 C/sec; or about 4 to about 80 C/sec; or about 4 to about 60 C/sec; or about 4 to about 40 C/sec; about 4 to about 30 C/sec;
about 4 to about 20 C/sec; or about 10 to about 150 C/sec; or about 10 to about 100 C/sec; or about
10 to about 80 C/sec; or about 10 to about 60 C/sec; of about 10 to about 40 C/sec; or about 10 to about 30 C/sec; or about 10 to about 20 C/sec. Finally, the reaction solutions are held at a final state to provide one or a plurality of amplified nucleic acid products.
Denaturing states can range generally include from about 90 to 99 C for times ranging from about 1 to 30 seconds. The actual times and temperatures are enzyme, primer and target dependent. For the Applied Biosystems (AB) multiplexed STR kit for amplifying human genomic DNA, about 95 C for about 5 sec. being preferred.
The annealing temperature and time influence the specificity and efficiency of primer binding to a particular locus within a target nucleic acid and are particularly important for multiplexed PCR reactions. The correct binding of a complete set of primer pairs during the annealing step can allow production of multiplexed amplification of a plurality of loci, for example, one or a plurality of full STR profiles with acceptable PI-IR and inter-locus signal strength balance. For a given primer pair, annealing states can range from about 50 C to 70 C and times from about 1 to 30 seconds. The actual times and temperatures are enzyme, primer, and target dependent. For the AB multiplexed STR kit for amplifying human genomic DNA, about 59 C for 15 seconds is preferred.
Extension temperature and time primarily impact the allele product yield and are an inherent property of the enzyme under study. It should be noted that the extension rates reported by the manufacturer are often provided for singleplex reactions;
extension rates for multiplex reactions can be much slower. For a given enzyme, extension states can range from about 60 to 75 C and times from about 1 to 30 seconds. The actual times and temperatures are enzyme, primer, and target dependent. For the AB multiplexed STR kit for amplifying human genomic DNA, about 72 C for about 5 seconds is preferred.
Preferably, for continuing a predetermined number of cycles, the reaction solution is heated from the extension state to the denaturing state at a third rate of about 1 to about 150 C/sec, or about 1 to about 100 C/sec; or about 1 to about 80 C/sec; or about 1 to about 60 C/sec; or about 1 to about 40 C/sec; or about 1 to about 30 C/sec; or about 1 to about 20 C/sec; 4 to about 150 C/sec, or about 4 to about 100 C/sec; or about 4 to about 80 C/sec; or about 4 to about 60 C/sec; or about 4 to about 40 C/sec; or about 4 to about 30 C/sec; or about 4 to about 20 C/sec; or about 10 to about 150 C/sec; or about 10 to about 100 C/sec; or about 10 to about 80 C/sec; or about 10 to about 60 C/sec; of about 10 to about 40 C/sec; or about 10 to about 30 C/sec; or about 10 to about 20 C/sec. Generally, the predetermined number of cycles is chosen to be about 10 to about 50 cycles, although fewer or more cycles may be used as necessary.
Final extension times can be reduced significantly until incomplete NTA begins to increase. For a given enzyme, final extension temperatures can range from about 60 to 75 C
and times from about 0 to 300 seconds. The actual times and temperatures are enzyme, primer, and target dependent. For the AB multiplexed STR kit for amplifying human genomic DNA, about 72 C for about 90 seconds is preferred.
In addition to the 3-step thermal cycling approach set forth above, this process is also amenable to 2-step thermal cycling approaches. In this approach, the reaction solutions are sequentially cycled between a denaturing state, and an annealing/extension state for a predetermined number of cycles. This approach utilizes primers designed to anneal at the extension temperature, allowing the annealing and extension steps to share the same temperature. The reduced number of temperature transition results in a further reduction in the cycle time.
In certain embodiments, a plurality of amplified nucleic acid products can be obtained in about 5 to about 20 minutes. In certain other embodiments, a plurality of amplified nucleic acid products can be obtained in about 5 to 10 minutes, about 1 to 5 minutes, or less than 5 minutes. Each amplified nucleic acid product can be generated starting from less than about ng of a target nucleic acid. Preferably, amplified nucleic acid products can be generated starting from less than about 5 ng or less than about 2 ng of nucleic acid, or less than about 1 ng of nucleic acid, or less than about 0.5 ng of nucleic acid, or less than about 0.2 ng of nucleic acid, or less than about 0.1 ng of nucleic acid, or less than about 0.05 ng of nucleic acid, or less than about 0.006 ng of nucleic acid.
In other embodiments, such as the identification of biological weapons agents in clinical or environmental samples or the diagnosis of bacterial, viral, or fungal infections in humans, plants, and animals, amplified nucleic acid products can be generated starting from at least one copy of a target nucleic acid. For example, a sample to be analyzed can comprise less than 1000 copies (e.g., 1 ĀØ 1000 copies), less than 400 copies, less than 200 copies, less than 100 copies, less than 50 copies, less than 30 copies, less than 10 copies or 1 copy of a target nucleic acid prior to the multiplexed amplification reaction.
In addition, less than a single genome equivalent of DNA can be utilized for amplification if the target nucleic acid locus is present in more than one copy in the genome.
In any of the preceding methods, the thermal cycling can be performed for a predetermined number of cycles to achieve sufficient amplification of the loci in the target nucleic acid as can be readily determined by one skilled in the art. For example, the predetermined number of cycles can range between about 10 and about 50 cycles, and preferably between about 20 and 50 cycles. Further, in any of the preceding methods, at least 2 loci of one or a plurality of nucleic acids can be simultaneously amplified.
Depending on the desired application, greater than four, 5 to 10, 10 to 20, 20 to 30 or about 10 to 250 loci are simultaneously amplified For example, for amplification of STR loci, 10-20 loci may be preferred.
Preferably, the temperature of the reaction solutions is cycled by a thermal cycler of the invention (supra). While it can be possible to utilize commercial block thermal cyclers for fast thermal cycling by the compensating for lagging response of the PCR
solution by setting the block temperature higher than the desired solution temperature on heating steps and setting the block temperature lower than the desired solution temperature on cooling steps, this mode of operation is cumbersome to implement as the temperature setpoints required to compensate for the slow ramping response must be determined empirically.
Furthermore, as feedback and control are still performed by the block and no monitoring of the solution temperature takes place, the repeatability and reproducibility of the profile can be influenced by external factors including the changes in the room temperature.
Hence, the temperature profile of the solution is not reproducible.
Many commercially available polymerases can be adapted for use in fast PCR
applications using the approaches described here. Typically, the nucleic acid polymerase has an extension rate of at least 100 bases/sec. A large number of polymerases available for PCR
amplification including Thermus aquaticus (Taq), Pyrococcus furiosus (Pfu), Pyrococcus woesei (Pwo), Thermas flavus (Tfl), Themus thermophilus (Tth), Thermus litoris (Tli) and Thermotoga maritime (Tma). These enzymes, modified version of these enzymes, and combination of enzymes, are commercially available from vendors including Roche, Invitrogen, Qiagen, Strategene, and Applied Biosystems. Representative enzymes include PHUSION (New England Biolabs, Ipswich , MA), Hot MasterTaem (Eppendorf), PHUSION
Mpx (Finnzymes), PyroStart (Fermentas), KOD (EMD Biosciences), Z-Taq (TAKARA), and CS3AC/LA (KlenTaq, University City , MO). A widely used enzyme for PCR
amplification for STR typing is the Taq polymerase, and the TaqGold variant is supplied with. the IdentifilerTm, Profiler, and COfilerTm kits.
In certain embodiments, the PCR conditions presented here can generate full STR
profiles from a human target nucleic acid with high efficiency, although production of a full profile is not required. A full profile for autosomal STR can comprise loci such as amelogenin, D8S1179, D21511, D7S820, CFSIPO, D351358, TH01, D13S317, DI6S539, D251338, D19S433, vWA, TPDX, D18S51, D5S818, FGA, or a plurality thereof.
Other STR
loci including mini-STRs, and Y-STR analysis. The criteria for optimization of the protocols include the generation of full profiles, signal strength, dynamic range, inter-locus signal strength balance, PHR, incomplete NTA, stutter, and total cycle time.
According one embodiment, protocols using the SpeedSTAR enzyme and the thermal cycler of the invention can reduce the total cycling time for biochip and tube reactions to 17.3 and 19.1 min respectively, to generate full STR profiles. In the protocol, the denaturing state is about 98 C for about 4 seconds, the annealing state is about 59 C for about 15 seconds, the extension state is about 72 C for about 7 seconds, and the final state is about 70 C for about 90 seconds.
In certain embodiments, the total cycling time for at least 10, 20, or 30 multiplexed PCR cycles can range from about 1 minute to about 90 minutes. Preferably, total cycling time for at least 10, 20, or 30 multiplexed PCR cycles ranges from about 1 minute to about 90 minutes; or from about I minute to about 85 minutes; or from about 1 minute to about 80 minutes; or from about 1 minute to about 75 minutes; or from about 1 minute to about 70 minutes; or from about 1 minute to about 65 minutes; or from about 1 minute to about 60 minutes; or from about 1 minute to about 55 minutes; or from about 1 minute to about 50 minutes; or from about 1 minute to about 45 minutes; or from about 1 minute to about 40 minutes; or from about 1 minute to about 35 minutes; or from about 1 minute to about 30 minutes; or from about 1 minute to about 25 minutes; or from about 1 minute to about 20 minutes; or from about 1 minute to about 15 minutes; or from about 1 minute to about 10 minutes or from about 1 minute to about 5 minutes. In other embodiments, the total cycling time for at least 10, 20, or 30 multiplexed PCR cycles is less than about 90 minutes.
Preferably, the total cycling time for at least 10, 20, or 30 multiplexed PCR
cycles is less than about 89, 85, 80, 75, 70, 65, 60, 55, 50, 45, 40, 35, 30, 25, 20, 15, 10, 5, 4, 3, 2, or 1 minute.
The invention contemplates an integrated biochip comprising one or a plurality of microfluidic systems, for performing the multiplexed PCR amplification of a plurality of loci within a nucleic acid sample as well as at least one other sample preparation and/or analysis method within the same biochip platform. For example, within each microfluidic system on a biochip, each having a flow direction from an inlet port to an outlet port, the system can comprise a plurality of reaction chambers, wherein a first reaction chamber of the plurality of reaction chambers is in fluid communication with the inlet port, and an ultimate reaction chamber of the plurality of reaction chambers is in fluid communication with the outlet port, and at least one microchannel fluidly connecting each consecutive pair of reaction chambers along the flow direction. At least one reaction chamber in each microfluidic system can be less than 200 Am from a contact surface of the biochip substrate to facilitate thermal communication with a thermal cycler of the invention for performing multiplexed PCR
within said reaction chamber.
Each of the remaining reaction chambers within each of the microfluidic systems of the biochip can be adapted for nucleic acid extraction, nucleic acid purification, nucleic acid hybridization, nucleic acid ligation, pre-PCR nucleic acid cleanup, post-PCR
cleanup, pre-sequencing cleanup, sequencing, post-sequencing cleanup, separation and detection, reverse transcription, pre-reverse transcription cleanup, and/or post-reverse transcription cleanup, electrophoretic separation, nucleic acid detection. The term "cleanup" as used herein means the removal of reaction components (including anions, cations, oligonucleotides, nucleotides, preservatives, enzymes, or inhibitors) that may interfere with any of the reaction chamber processes listed above.

The Examples which follow are illustrative of specific embodiments of the invention, and various uses thereof. They set forth for explanatory purposes only, and are not to be taken as limiting the invention.
EXAMPLES
Example 1 Custom Thermal Cycler and Microfluidic Biochip A thermal cycler of the inventionƵ as shown in Figure 1A, was used to perform fast cycling by allowing the PCR reaction solution temperatures to be heated and cooled rapidly, controllably, and reproducibly. This instrument accepts a 16-chamber microfluidic biochip and consists of a high output thermoelectric cooler/heater mounted to a high efficiency heat sink. Each of 16 PCR reaction solutions was placed into an individual chamber of the microfluidic biochip, coupled to the heat pump by applying a 0.2 MPa of compressive pressure with a clamping mechanism. Figure 1B shows a photograph of the 16-samp1e disposable plastic microfluidic biochip. Each PCR chamber is 500 vim deep and approximately 1 mm wide and holds 7 1 of PCR reaction solution.
Instrumentation and Temperature profiles In the following examples, all amplification reactions in tubes were performed with an Eppendorf MastercylerTm ep gradient S (Eppendorf North America, Westbury, NY).
Block temperature profiles of the above instrument were obtained using a 127 Am diameter type K thermocouple sensor which was attached directly to the block. For reaction solution profiles a 127 tim diameter type K thermocouple sensor was placed in the 20 pd_, reaction solution, within a thin-walled PCR tube. Data acquisition was performed with an Omega HH506RA Multilogger thermometer set to acquire data at a rate of 100 Hz.
Amplification reactions in biochips were performed using the thermal cycler of Example 1 with 16-sample plastic biochips as the reaction vessels. The solution temperature within the microfluidic biochip was monitored by inserting a thermocouple into a sensing chamber within the biochip.
PCRĀØ reaction mix components and cycling conditions Multiplex PCR reactions were performed with the AmpFESTRO Profiler Plus ID
PCR Amplification Kit (Profiler Plus ED kit) (Applied Biosystems, Foster City, CA) using 9947A genomic DNA (Promega, Madison, WI) as a template. Polymerases used for amplification were either AmpliTaq Gold DNA Polymerase (TaqGo1d1-11) supplied with the Profiler Plus ID kit or other polymerases: SpeedSTAR HS DNA Polymerase (SpeedSTAR) (Takara BIO USA Inc., Madison, WI), KOD Hot Start DNA Polymerase (KOD) (EMD
Biosciences Inc., Gibbstown, NJ), or PyrostartTM Fast PCR Master Mix (PyroStart) (Fermentas Inc., Glen Burnie, MD). Multiplex PCRs with other polymerases were carried out using the labeled multiplex primer set from the Profiler Plus II) kit in combination with the polymerase specific buffers and dNTPs. All tube PCRs were carried out in 0.2 mL
thin-walled PCR tubes (Eppendorf North America, Westbury, NY) using the Eppendorf MastercylerTm ep gradient S. All biochip reactions were amplified in the thermal cycler of Figure lA using 16-sample biochips.
The following PCR reaction mixtures were prepared and used for thermal cycling:
Standard TaqGoldTm reactions:
Standard TaqGoldmi multiplex reactions consisted of 9.55 AL Profiler Plus ID
reaction mix, 1 ng 9947A genomic DNA, 5 AL Profiler Plus ID Primer set and 2.25 U
TaqGoldTm in a 25 AL reaction volume. Cycling conditions (block temperatures and times) were chosen following the manufacturers recommendations and set to an initial 95 C for 11 min (hot start) followed by 28 cycles of 1 min at 94 C
(denaturing), 1 min at 59 C (annealing), 1 min at 72 C (extension) and a final extension of 45 min at 60 C.
Optimized TaqGoldTm reactions:
TaqGoldTm reactions optimized for fast cycling were carried out in a 10 AL
reaction volume containing 3.82 AL Profiler Plus ID reaction mix, 1 ng 9947A
genomic DNA, 2 AL Profiler Plus ID Primer set and 0.9 U TaqGoldTm. Reactions were cycled at 95 C for 11 min, 28 cycles 10 s, 98 C; 45 s, 59 C; 30 s, 72 C and a final extension of 15 min at 72 C.
SpeedSTAR tube reactions:
SpeedSTAR PCR mix components for tube PCR were: 2 AL Profiler Plus ID
primer set, 9947A genomic DNA, lx Fast Buffer I (Takara BIO USA Inc., Madison, WI), 200 AM dNTPs and 0.315 U SpeedSTAR in a 10 AL reaction volume. Cycling conditions for fast performance were set to: 1 min at 95 C (enzyme activation) followed by 28 cycles of 4 s at 98 C, 15 s at 59 C, 5 s at 72 C and a 1 min at 72 C
final extension.

SpeedSTAR biochip reactions:
For biochip PCR the 7 AL reaction mix contained 1.4 AL Profiler Plus ID
primer set, 9947A genomic DNA, lx Fast Buffer I buffer, 200 ktM dNTPs and 0.42 U
SpeedSTAR. Cycling parameters were set to 70 s at 95 C, 28 cycles of 4 s, 98 C; 15 s, 59 C; 7 s, 72 C and a final extension of 1:30 min at 70 C.
KOD reactions:
Amplification with KOD were performed with 2 AL Profiler Plus ID primer set, lx KOD buffer (EMD Biosciences Inc., Gibbstown, NJ), 200 ktM dNTPs, 1 ng 9947A genomic DNA, 1.5 mM MgSO4, 0.2 U KOD in a 10 AL reaction volume.
Cycling conditions were: 2 min, 95 C followed by 28 cycles of 4 s, 98 C; 30 s, 59 C; 10 s, 72 C with a final extension of 1 min, 72 C.
PyroStart reactions:
Reaction mixtures with PyroStart in a lx final concentration also contained 2 AL Profiler Plus ID primer set and 1 ng 9947A genomic DNA in a 10 ktI, reaction and were cycled at: 1 min, 95 C and 28 cycles of 4 s, 98 C; 20 s, 59 C; 30 s, followed by a final extension of 1 min at 72 C.
Multiplex PCR with other STR typing kits:
The suitability of SpeedSTAR to generate full STR profiles with other STR
typing kits (AmpFeSTR Identifiler (Identifiler), AmpHSTR COfiler PCR
Amplification Kit (COfiler), (Applied Biosystems) was tested in tube and biochip with the reaction conditions as described above for SpeedSTAR with the Profiler Plus ID kit. In these reactions, the Profiler Plus ID primer sets were replaced with the primer set from each of the kits.
Reproducibility Reproducibility studies in tube and biochip were performed with TaqGold-T-mĀØ
and SpeedSTAR using lng 9947A genomic DNA as a template. For tube reproducibility individual reactions were prepared. Biochip reproducibility was determined in 3 biochip PCR runs with 8 reactions each.
Sensitivity Sensitivity studies for SpeedSTAR amplification in tube and biochip were performed using the following amounts of 9947A template DNA: In tube: 4 ng, 2 ng, 1.5 ng, 1 ng, 0.5 ng, 0.25 ng, 0.125 ng, 0.1 ng, 0.05 ng, 0.03 ng, 0.02 ng, 0.01 ng, 0.006 ng;
in biochip: 4 ng, 2 ng, 1.5 ng, 1 ng, 0.5 ng, 0.25 ng, 0.1 ng, 0.05 ng, 0.025 ng, 0.02 ng,Ƙ015 ng, 0.01 ng, 0.006 ng. The reactions at each template level were performed in duplicate.
STR separation and detection instrumentation Amplified products were separated and detected using the Network Biosystem Genebench-FXTm Series 100 (Pyzowski and Tan, Advances in Biochip-Based Analysis: A
Rapid Field-Based Approach 59th Annual Meeting of the American Academy of Forensic Sciences San Antonio, TX, February 19-24, 2007). This instrument was developed and optimized specifically for STR analysis. To 2.7 AL of each amplified product 10.2 AL
Hi-Di Tm formamide and 0.1 AL of Genescan 500 LIZ internal lane standard (both Applied Biosystems, Foster City, CA) were added. After denaturation at 95 C for 3 min and snap cooling on ice, samples were loaded into the separation chip and electrophoretically moved into the separation channels by applying a 350 V/cm electric field for 90 seconds. This was followed by the application of a 150 V/cm electric field along the separation channel to separate the DNA fragments. All separations were carried out at 50 C.
Data analysis Data was analyzed with the GeneMarker HID STR Human Identification Software, Version 1.51 (SoftGenetics LLC, State College, PA). Signal strengths were normalized to the internal lane standard and the percentages of stutter, incomplete NTA as well as PHR
were determined. PHR is calculated by dividing the lower signal strength allele by the higher signal strength allele within the locus. The level of incomplete NTA is calculated by dividing the signal strength of the template fragment (-A) by the signal strength of the adenylated fragment (+A).
Example 2 Temperature Profiles of Thermal Cycling Instruments and Reaction Solutions in Conventional PCR Tubes and Microfluidic Biochips Amplification reactions were performed in thin-walled PCR tubes using a commercial thermal cycler and in microfluidic biochips using the thermal cycler of Example 1. For tube reactions, the Eppendorf MastercylerTm was utilized. Figure 2A shows the temperature of the block and the reaction solution within a tube for one of the 28 thermal cycles using a conventional STR cycling protocol. The MastercyclerTm heating and cooling system is based on a heat pump with an integrated block for tube insertion. The time and temperature setpoints are 1 minute at 98 C for denaturation, 1 minute at 59 C for annealing, and 1 minute at 72 C for extension. A comparison of the temperature profiles for the heat block and the reaction solution shows a lag in the response of the solution temperature relative to the block temperature. The measured heating and cooling rates of the block are 5.6 C/sec and 4.9 C/sec and of the solution are 4.8 C/sec and 3.3 C/sec. The block makes the temperature transition from extension (72 C) to denaturation (98 C) in 14 seconds, but the solution does not achieve the setpoint temperature for 39 seconds. Transitions between the denaturation and annealing steps (59 C) take 10 and 27 seconds and between the annealing and extension steps take 7 and 24 seconds for the block and solution respectively.
The temperature profiles of the Eppendorf MastercylerTM block and the reaction solution for one of the 28 thermal cycles under fast cycling conditions are shown in Figure 2B. The time and temperature setpoints are 5 seconds at 98 C for denaturation, 15 seconds=
at 59 C for annealing, and 5 seconds at 72 C for extension. However, the delayed and dampened response of the solution prevents it from achieving the desired setpoint temperatures.
_ The temperature profiles of the heat pump and the reaction solution for one of the 28 thermal cycles for the thermal cycler of the invention using fast cycling conditions were also determined (Figure 3). For the determination of the reaction solution temperature, a sensing chamber within the biochip was used. The time and temperature setpoints are 4 seconds at 95 C for denaturation, 15 seconds at 59 C for annealing, and 7 seconds at 72 C
for extension.
The measured heating and cooling rates of the heat pump are 21.5 C/sec and 21.7 C/sec, and the measured heating and cooling rates of the reaction solution are 14.8 C/sec and 15.4 C/sec.
Accordingly, the thermal cycler of the invention is capable of heating and cooling the reaction solution at a rate that is 3 to 5 times faster than the commercial block-based cycler.
The transition times between extension, denaturation, and annealing steps for the heat pump are 1.7, 2.1, and 0.7 seconds and for the solution 2.7, 4.5, and 2.2 seconds.
The thermal cycler of the invention allows the reaction solution to reach the required temperatures approximately 7-fold faster than the block-based cycler, resulting in defined and controlled incubation temperatures and times under fast cycling conditions.

Example 3 Evaluation of PCR Enzymes in Tubes A large number of polymerases were evaluated for potential use for fast, multiplexed STR analysis, and candidates were selected based in part on hot-start activation time and extension rate. The reported properties of the four polymerases selected for experimental evaluation compared with recommended conditions for TaqGoldT are presented in Table 1(A).
1 1 l TABLE 1A = Reported Polyrnerase characteristics 1 I l l 1ĀØ

Potymerase l ATG l SpeedSTAR PyroStart l KOD
3-5' Exonuclease activity No = Yes, <20% No Yes Generation of 3'-dA overhangs Yes Yes, >80% Yes No Hot Start mechanism Chemical modified Antibody Chemical modified Antibody initial activation 95*C / 11 min 95 C / 1 min 95*C / 1 min 95 C / 2 min Elongation rate (nucleotides/sec] 16.67 l 100-200 40 d 1 1B - Optimized performance of polymerases in tube reactions
11 k Standard ATG Optimized ATG SpeedSTAR PyroStart KOD
Cycling conditions 95 C / 11 min 95 C / 11 min 95 C 1 1 min 95 C / 1 min 1 95 C / 2 min 94 C / 1 min 98 C / 10sec 98 C / 4 sec __ 98 C / 4 sec 98 C /
4 sec 59 C / 1 min x 28 59 C I 45 sec x 28 59 C I 15 sec x 28 59 C / 20 sec x 28 59 C / 30 sec x 28 72 C / 1 min 72 C / 30 sec 72 C / 5 sec 72 C / 30 sec 72 C
/ 10 sec 60 C / 45 min 72=C/ 15min 72 C / 1 min 72=C/ 1 min 72 C i 1 min Amplthcation time 145.1 min 71.67 min 19.13 min 33.12 min 29.47.min Signal Strength range pail 561-1655 600-3876 945-3669 Stutter range 4.18.11.16% 3.91-13.77% 6.49-13.56% 6 21-15 91% 4.46-23.61%
NTA range 1.54-7.67% 1.93-20.13%
3.07.19.68% 3.01-23.09%
PHR 0.88-0.93% 0.74-0.96% 0.83-0.93% 0.71-0.94% 0.61-0.94%
I
The evaluated enzymes have reported extension rates ranging from approximately nucleotides/second; in general, the reported extension rates are based on singleplex amplifications and may be somewhat lower for multiplex applications.
PCR conditions in tubes were initially investigated for these four enzymes with the goal of achieving full STR profiles in the least amount of time. For all reactions, 1 ng of human genomic DNA was amplified using primer pairs from the Profiler Plus lD
kit and vendor recommended buffers and enzyme concentrations, and resulting profiles were separated, detected, sized, and quantified using Genebench-FX11" Series 100.
Various times and temperatures for the denaturation, annealing, and extension steps were determined to give total times for PCR amplification with signal strengths suitable for STR
interpretation ranging from 19.13 minutes for SpeedSTAR to 71.7 minutes for TaqGoldill [Table 1(B)].
Method conditions of the invention allow amplification to be performed 2-10 fold more rapidly than recommended conditions for TaqGoldTm.
Further evaluation of the enzymes for forensically relevant performance includes signal strength, levels of stutter and incomplete NTA and PFIR [Table 1(B)].
All enzymes are capable of performing highly multiplexed amplification using the Profiler Plus ID
primers. Signal strengths for SpeedSTAR, Pyrostart, KOD, and optimized TaqGoldlil reactions are all either approximately the same or higher than those generated using standard TaqGoldrĀØm- PCR conditions.
With respect to incomplete NTA, both SpeedSTAR and PyroStart as well as optimized TaqGoldTm reactions exhibited levels that are up to three times higher than that of standard TaqGoldi'm reactions. For most alleles, levels fall below the 15%
interpretation threshold. Those alleles having higher levels of incomplete NTA can be decreased to below the 15% interpretation threshold as discussed below. The KOD polymerase possesses 3'-5' exonuclease activity and does not generate fragments with A-overhangs;
accordingly, all alleles were 1 nucleotide shorter than their allelic ladder counterpart.
The relative levels of stutter observed for optimized TaqGoldTm, SpeedSTAR and PyroStart reactions are similar to the range of stutter produced with standard TaqGoldTm reactions; the range of stutter generated with KOD is slightly higher than the stutter for standard TaqGoldTm.
Example 4a Fast PCR Protocol Using SpeedSTAR Polymerase in Tubes and Biochips Based on the results presented above, the SpeedSTAR polymerase was selected for further evaluation in biochips with the goal of minimizing the total cycling time and achieving full STR profiles that satisfy signal strength, PHR, incomplete NTA
and stutter interpretation requirements.
The time and temperature setpoints for amplification using SpeedSTAR in the microfluidic 16-sample biochip on the thermal cycler of the invention are 70 seconds 95 C
for hot-start activation followed by 28 cycles of 4 seconds at 95 C for denaturation, 15 seconds at 59 C for annealing, and 7 seconds at 72 C for extension. A final extension of 90 seconds at 72 C is performed for a total protocol time of 17.3 minutes. Tube reactions in the Eppendorf Mastercycler were performed in 19.13 minutes comprising of block times and temperatures set to an initial activation time of 1 minute at 95 C, 28 cycles of 4 seconds at 98 C, 15 seconds at 59 C and 5 seconds at 72 C followed by a final extension of 1 minute at 72 C.
Figures 4A and 4B show STR profiles generated with the preceding SpeedSTAR
cycling conditions in (Figure 4A) 7 AL biochip and (Figure 4B) 10 AL tube reactions using 0.5 ng of DNA and Table 2 presents signal strengths for all Profiler Plus ID
alleles from the SpeedSTAR biochip and tube reactions as well as TaqGoldTm in tubes using the standard protocol. Signal strengths of the 0.5 ng SpeedSTAR biochip reactions are on average approximately 2 times higher than those of the lng standard TaqGoldmi reactions, while the signal strengths of the 0.5 ng SpeedSTAR tube reactions are on average approximately the same as those of the TaqGoldTm reactions.
TABLE 2 - Con;parison of' signal strengĀ¶ th, PHR. NTA and stutter for S4eedSTAR'b;ochip and (ube reactions and ATG standard reactions' I I
SpeedSTAR biochip reaction SpeedSTAR tube reaction I I
Standard ATG reactions Locus Allele -1 Signai 1 PHR 1 NIA (%) Stutter Signal - PHR NTA (%) Stutter I
1 Signal strength PHR NTA (%) Stutter ______________ strength (%) strength (%) 11 Averac-S-TDEV Average 1 STDEV Average I STDEV Average I STDEV
03S1358 14 1404.218 9.08 727.11 9.74 I 831.69 167.25 1 1.88 0.52 0.79 0.81 0.92 0.04 D3S1358 15 1110.915 8.05 10.35 895.12 10.50 8.14 1 802.99 141.78 1.54 0.34 5.31 0.23 vWA 17 2338.633 6.14 1346.81 6.62 1 765.61 83.69 0.95 0.65 4.22 0.44 vWA 0.90 1 18 2216.64 6 83 12.87 875.84 6.78 11.96 1 736.85 88.40 "8 4 23 0.19 7.38 948 _ FGA 23 747.5319007 4.21 877.22 2.54 1 735.41 130 32 a 1 2.14 0.45 FGA 24 648.8992 3.34 9.72 840.03 8..-a 2.30 8.32 1 727.02 122.82 -.. n 1 -a, 1.98 0.44 7.19 0.43 Amelogenin X 5645.423 I 4.04 1324.78 2.02 1 1655.65 343.77 3.35 0.49 D8S1179 13 3784.38 5.62 1 10.70 1012.17 5.47 11 56 1 1405.57 105 18 I 4.52 0.58 I 651 062 1321S11 30 2008.992 3.15 I 13.05 787.70 3.45 l 13.29 1 1280.31 81.30 I 300 0.66 7.33 0.60 018551 l 15 1655.991 6.90 11.44 924.04 5.48 9.09 1 879.42 137.76 4.68 0.74 7.89 0.80 0.70 0.72 0.88 0.05 068 11.16 0.52 1191 21910457643973 97: 5358 184:53 16:017466 I
= 83:9827 183.7903 1 1858148.1084 m125:7758 D5S818 3.71 0.17 4.94 0.44 013S317 11 3906.373 3.32 6.78 1867.36 I
3.21 7.74 h 1643486.9560 119613:4827 0.89 - 2.33 0.28 4.18 0.47 075820 10 1232.908 0.03 7.23 647.24 0 73 8.01 1 n n. 4.69 0.99 ,D7S820 , 11 , 1149 849. . 10.16 , 7.37 , , 469.59 , = 10.00 , 5.96 I I 561.37 , 92.47 1 0.08 7 0.72 , 4 57 , 0.62 , Example 4b Allele Characterization of Fast PCR Using SpeedSTAR Polymerase in Tubes and Biochips In order to characterize the products of fast PCR reactions from Example 4a, quantification of PHR, incomplete NTA and stutter was performed. Biochip and tube reactions using the SpeedSTAR polymerase show more inter-locus peak height imbalance compared to that for the TaqGoldTm reactions. The PHR for alleles generated in biochip reactions is between 0.70 and 0.95 and is approximately the same in tubes; all fall within acceptable interpretation guidelines. Reactions using SpeedSTAR have PHR that are approximately 10% lower than those determined for standard TaqGoldTm reactions.
Similarly, the level of incomplete NTA for most alleles in both biochip and tube reactions using SpeedSTAR are approximately the same (2.0 and 10.6%); both are approximately 2 times higher than for TaqGoldTm control reactions. The exception is incomplete NTA for the D3S1358 alleles, which is 4.8 to 7 times higher with SpeedSTAR than with TaqGoldTm; even in this case, the level of incomplete NTA is below 12% for the SpeedSTAR
enzyme. Finally, the level of stutter in both biochip and tube based reactions using SpeedSTAR
is between approximately 6.0 and 14.1%, on average approximately 1.6-fold higher than that for standard TaqGoldTm tube reactions.
The microfluidic biochip reactions using 0.5 ng template DNA generate signal strengths that are approximately 2 times higher than those for standard TaqGoldTm reactions using 1 ng template. This result suggests that the SpeedSTAR enzyme in the biochip and the TaqGoldTm enzyme in the conventional reaction act with similar efficiencies;
the DNA
.

concentration in the biochip is approximately 1.8-fold that in the tube, which corresponds to the 2 fold greater in signal strength. In contrast, the fast tube based reactions are less efficient than the control TaqGoldTm reactions; the approximately 40% reduction in product yield is likely the consequence of the poor cycling profile that results when commercial thermal cyclers are used for fast thermal cycling. Even in this circumstance, signal strengths are well over the levels required for interpretation and can be raised significantly by increasing the extension time by a few seconds per cycle (data not shown).
Repeatability and reproducibility of the signal strength for fast PCR reactions in biochips and tubes are similar to those in conventional reactions.
The inter-locus allele signal strength for the fast biochip and tube reactions shows a higher level of imbalance as compared to the TaqGoldTm reaction. The inter-loci signal strength balance is influenced by numerous factors including primer concentration, annealing temperature and time, and molecular weight of the loci. The STR amplification kit used for these experiments has a set of primer concentrations that are optimized for the TaqGoldTm enzyme and the recommended cycling protocols. The signal strengths of the loci can be modified by adjusting the primer concentrations utilized in the amplification reactions (Henegariu et al., Biotechniques 1997, 23, 504-11).
The relationship between signal strength and template level for fast biochip and tube reactions is as expected with signal strength generally increasing with template. Good peak morphology is observed for all alleles at high template levels of 4 ng (which generate alleles with signal strengths of greater than 12000 RFU). At template levels of 0.03 ng and below some allele drop-out occurs. This effect is observed when amplification reactions are carried out with limited number of template DNA strands in the solution leading to stochastic amplification (Walsh et al., PCR Methods Appl. 1992, 1, 241-250). The presence of readily detectable signal for both the high-signal strength alleles and low-signal strength alleles at a template level of 0.006 ng, demonstrates the high sensitivity of the fast biochip and tube reaction coupled with Genebench-FX-rm Series 100 separation and detection, demonstrating the utility of this system for low copy number analysis. Taken together, this data also suggests that the fast PCR approach and the thermal cycler of the invention and Genebench instrumentation have a high template dynamic range.
Example 4c DNA Template Levels and Allele Characteristics in Fast PCR Reactions The effects of template DNA on signal strength for fast PCR reactions using SpeedSTAR polymerase in (Figure 5A) biochip and (Figure 5B) tube reactions are presented in Figures 5A and 5B. The alleles selected for analysis were Amelogenin, the allele with the highest signal level in the STR profile and FGA 23 and 24 and D7S820 10 and 11, the alleles with the lowest signal levels in the profile. Signal strengths for all alleles increase as the DNA template level increases from 0.006 ng to 4 ng in both SpeedSTAR biochip and tube reactions. At a template level of 0.006 ng, signal strengths for the amelogenin peak of 111 RFU for biochip and 58 RFU for tube reactions were observed. At a template level of 4 ng, signal strengths of 12680 RFU were seen for biochip and 5570 RFU for tube reactions. All alleles observed in both reaction types showed good peak morphology.
For fast biochip reactions (Figure 6A), PHR is between 0.6 and 1.0 for template levels ranging from 0.05 to 4.0 ng. For template levels below 0.05 ng, PHR
decreases until 0.025 ng, when instances of allelic dropouts occur and PHR of zero are observed. Similar results are observed for fast tube reactions, although they generally exhibit somewhat lower PHR than biochips reactions (Figure 6B). For biochip reactions, the level of incomplete NTA is 15% or less for template levels of 2.0 ng and below. For tube reactions, the incomplete NTA levels surpass 15% at template levels of 1 ng and increase dramatically by 4 ng.
Two major differences between biochip and tube reactions are the temperature profiles of the reaction solutions and the relative concentration of template and polymerase.
The level of incomplete NTA decreases as more polymerase is available. For biochip reactions experimental data show that over a DNA template range from 0.5 - 4.0 ng the level of incomplete NTA decreases by approximately 50% as the amount of SpeedSTAR
polymerase increases from 0.3U to 1.2U (Figures 7A and 7B). The level of stutter for fast biochip and tube reactions was relatively constant and generally less than 15%
for all alleles over a template level range of 0.25 ĀØ 4.0 ng (Figures 8A and 8B).
The speed of an STR amplification reaction is only relevant if the reaction itself generates actionable data that meets forensic interpretation guidelines. The FBI has general guidelines that are used for STR interpretation, and individual laboratories set thresholds that must be met before a profile can be considered acceptable based on their validation work (Holt et al., i Forensic Sci. 2002, 47(1), p. 66-96; LaFountain et al., J.
Forensic Sci., 2001, 46(5), 1191-8).
The conditions presented herein can generate fast STR profiles that meet these guidelines. PHR for 0.5 ng template in biochip and tube reactions meet with the interpretation guidelines that state a level of 0.6 or greater is required and are consistent with previously reported results (Leclair et al., J. Forensic Sci. 2004, 49, 968-80). For higher DNA template amounts, PHR remain relatively constant but are lower than those for the lng TaqGoldTv.1 reactions. For low copy numbers, the PHR is dominated by amplification due to stochastic fluctuations.
The level of incomplete NTA is based on the ability of the polymerase to fully adenylate all STR amplicons. For conventional amplification, this is accomplished by attaching a "pigtail" to the primer and increasing the final extension time.
The level of incomplete NTA for 0.5 ng biochips and tube reactions described herein are within interpretation guidelines.
Levels of incomplete NTA increase with increasing DNA template (a consequence of the increasing ratio of DNA to polymerase) and can be reduced by increasing the amount of polymerase, extension time per cycle, and final extension time. The later two approaches are not well-suited to fast multiplexed amplification, as they increase the reaction time.
Increasing polymerase concentration is effective and compatible with fast PCR.
Stutter is a result of DNA strand slippage during extension (Walsh et al., Nucleic Acids Res. 1996, 24(14), 2807-12). The level of stutter described here for the 0.5 ng biochip and tube reactions fall within the interpretational guidelines and are also consistent with previously cited reports. As expected, the level of stutter appears to be independent of the DNA
template level.
Example 4d Repeatability and Reproducibility Studies The repeatability and reproducibility of the fast biochip (Table 3A) and tube (Table 3B) reactions using the SpeedSTAR polymerase were evaluated by performing 24 identical PCR reactions in 3 PCR biochips and by performing 5 identical tube reactions.
For biochip reactions, the confidence value (CV) for signal strength ranges from 17 to 24%
and for tube reactions from 15 to 34%. The CV for standard TaqGo1dn'71 reactions is between 6 and 21%.

=
= TABLE 3 = Re. ..ucibili of = STAR, biochi. 3A and tube 38 reactions 1111111.11.1111.1111111.111.1.1011111MINIMIMENNIMill A: SpeeraSTAR biochip reactions 1.111111111111 .111.111.11111..MME11.1 Allele Signal Strength (FtFU) PHR
NIA (%) Stutter (%) _ IMMINIUMERWERIZI Max Min Avera. e STDEV Max IIIMMIZMILEIZIIIMINWAMM Avera e STDEV Max Min 03S135814 l 1235.40 27143 1963.95 781.79 0.85 0.11 1.00 0.63 9.11 1.77 11.86 6.64 MEIMMINE
CERBENZIEMENEXIMIIIIEEKI 689.23 11111.111.1.111111M111.11111.130.1.4'MIEMIRMI
576 MUM 9=84 2.62 raglii11111111111=1117firEll 3818.46 MEM 0.81 MENNINWEEBEECEMEEE11111=1111111111111111111=1111=11111111111MIZEKEEMMEEMINEDEEN
NEEMEINBI 11.78 MIERIIMILEIIIIIIIIBBINIERE111=1111111MMICOM 0.99 K131111=33MINCE1111110011111111311111=111111=1111111111111M
MEM. 794.52 SM. 1109.30 11E13 11111111=111M1111.12311 0.48 MiliEllIECERI
0.95 12.18 8.63 1=1.11. 5085 29 IIECIIIIIIEMIEMilmmill111111111111111M1M1111111111111/111111 0,40I'6 =IIIMIEUEMEin 5200 08 IECEIONIMEM111111111=1111111111111MINEIMIIIMENWERMILIEMIDEINIIICIBIIME1311 10.01 D31111111LIIIIZEINEEIMIEMB111111111111111111111.11111=11111118001111111:13:1111 11111:1111IXEMEEEMIlarel 10.73 IXERE1211111EIMICEEDIEMOINIEEMEE=MINIIIIIIM111111111111=11111011101111113011111 rENI 000 10.61 0.64 5M4 9.04 D18551.19 IMIMERIER 2549.69 111=11110EEIIIIME1111113111111111111=10111111E161111M011 0.00 III8E1111113133111111131311 12.96 CIERIMIIERIECI 500.56 IEMEEIIIEEEEMIIMIIIMIIIIMMIIIOMMIIIIIIIIMIILM 1.88 RECEIMINXIM 8.90 EZIEM 9.89 8.35 MEW1 4097.95 EIZIENICEIMEMINI11111111=1111111111111=1=113111111:131111K9IENIEUEN3E5111111XEM
2.95 6.09 D7S320,10 MEMEENIMEM 3262.80 IMMIIIIMIN 0.09 MEM 0.69 6.68 0.60 Egimulimmommionmm.
D75820.11 MOEN 309 99 FIE*1II1MELIMM1111111111111=111111111=1=11101111111333111111aMMEEMENEINIXIMMEN
6.42 CV Min: 4%
CV Max: 24% CV Max: 14% CV Max: 28%
CV Max: 9%
.-1101111111=1M11111.1111111.11111.1.1111M111.110.111.11111111111.111111.1MMIMMII

B. S.eedSTAR tube reactions 11111111111111111111111111111111M11111111=MINIM1111111111MMIIIIIMIIIIII
Melo Si=nal Strength (RFU PHR
NTA (%) Stutter (%
_1.11122ThEEIZIIIIIIMMUNIMEMI=IIKIEMIEMEMZEIIMMEERThEMI Auera.e STDEV Max Min 03S1358 14 I 1718.86 464.62 2321.62 1249.71 0.86 0.03 0.94 1.3311.1321. 0.44 I 20.04 18.84 IMEME 1455.28 285.03 Naill 1110 96 11=E=.1111.11111111111M.11 19 68 0.78 20.71 Mignmum 0.49 Elm 7.65 1934,44 299 00 2150 18 EOM 0 83 Nam 0 98 mffloinimmum 12.32 11161EEMIIIIM
1722.47 450.99 2439.38 EMI
11111111111111111111111111111111E111111113111111 12.29 1E111311111EIMMiJ.1'III 13.37 12.18 firMallillEfOR 269.29 EMEEMEMEMIKEIMNIIIIIII 0.99 0.80 MillME:16011111311111111111111111111111=11111111111 8.90 3669.80 844.56 EMI 2799.39 111111111111111111111111111111111111111111111=2111111111:12111 5.41 4.68 D8S1179,13 2447.48 658.60 NEM 1820.49 ..11111111111111111111111.1111.1NEEMNI 8.61 aminirnimmis 10.86 9.72 MOE= 1628.98 436.18 5.26 4.46 11011.111110E31111=11 11.84 oamnarisminommunniml 1066.52 111131111111131111111101111MEMEMKEIMEMMICINI 8.67 0.31 10.09 9.30 OMEIBMINEEKIETEDIIMEI 963.18
12.28 055818.11 3.112,19 111371=115MUI1sIEIM11111111111111111111=11=IIIIIIIIIMEE111111001111 6.47 6.02 1111130111M1111 8,86 8.03 MEM= 3093 19 WEIECNIEBEINCIEN1111111111111=11=111111MMIZEIMIENEITIMMIIIIMIIIIIINNIIIMIN 6 D75820.10 1009.46 BENIESEKII 780 76 .111111=111111111111311111111:01111111131111KITINKJ.8 6.86 D75820.11 6.15 CV Min: 2%
CV Max: 34% CV Max: 21% CV Max: 13%
CV Max: 6%
The CV for PHR is up to 14% for biochips and 21% for tube reactions, compared to the 5% to 10% range observed for standard TaqGoldTm reactions. CVs for incomplete NTA
in biochip reactions vary between 6% and 28%, and for tube reactions between 2 to 13%.
Again, these variations are similar to the 4 to 28% range observed for standard TaqGoldTm reactions. The CVs for stutter in biochips are 4 to 9%, in tubes 2 to 6%, and are also similar to the range of 4-13% observed for standard TaqGoldTm reactions.
Example 4e Compatibility with Other Commercially Available STR Kits Using the same fast biochip and tube conditions described above, a series of samples were evaluated using primer sets from the COfilerml and IdentifilerTm kits.
Figures 9A and 9B show the achievement of full profiles using these primer sets using the thermal cycler of the invention, the SpeedSTAR enzyme, and the protocols described herein. Each is suitable for these commercially available kits as well. Although full profiles were achieved, imbalance in the signal strengths across the loci was observed.

Example 5 Fast Sequencing With the Thermal Cycler The thermal cycling instrument and methodology can also be applied to fast DNA

sequencing reactions. In this implementation of the fast thermal cycler, the instrumentation and biochip are the same as that used for PCR. Different reaction solutions, polymerase and cycling temperatures are applied for the sequencing reaction. The currently commercially available sequencing reactions take 49 min (for GE Amersham DYEnamicTm ET
Terminato Cycle Sequencing Kit) and 2.25 hr (for AB Big Dye V3.1. Utilizing the NetBio thermal cycler, with conventional reagents, allowed the sequencing reaction time to be reduced to 21 minutes.
Fast sequencing has been achieved using the thermocycler disclosed herein and biochip comprising 16 lanes. The final reaction volume in the chips was 7 L.
Half strength sequencing reactions were set up with the DYEnamicTm ET Terminator Cycle Sequencing Kit from GE Healthcare following the manufacturer's protocol. All volumes were scaled down accordingly to accommodate the 7 AL final volume. Template for the reaction was 0.1 pmol B. subtilus with a fragment size of 343 bp.
Three cycling protocols were demonstrated with the first protocol consisting of 30 cycles of (20 s at 95 C, 15 s at 50 C and 60 s at 60 C) (total cycling time is 51.7 min), the second protocol consisting of 30 cycles of 5 s at 95 C, 15 s at 50 C and 30 s at 60 C (total cycling time is 29 min) and a third protocol consisting of 30 cycles of 5 s at 95 C, 10 s at 50 C and 20 s at 60 C (total cycling time of 21.6 min). Each sequencing reaction was cleaned-up with ethanol precipitated, and separated on Genebench FX Series 100. The average PHRED scores for sequencing a 343 bp PCR product for the 3 cycling protocols were 282, 287, and 279 respectively; demonstrating that sequencing of a 343 bp product can be achieved in chip in less than 22 min. Figure 10 shows the DNA sequence of the fast DNA
sequencing protocol.
In general, biochip based multiplexed amplification of one or more nucleic acids utilizing the systems and methods described herein have the advantage of providing amplified nucleic acid products in significantly shorter overall reaction times with respect to reactions run in thin-walled tubes and utilizing presently commercialized thermal cycling units.

Claims (3)

We claim:
1. A thermal cycler system comprising:
a temperature control element (TCE) having a first surface;
a substrate comprising a sample chamber comprising a solution, said sample chamber positioned in thermal communication with said first surface, and a sensing chamber comprising a thermosensor, wherein the sensing chamber is fabricated to have the same material stack-up as the sample chamber, and configured and positioned in the substrate at an analogous position to that of the sample in the sample chamber so as to simulate conditions within said sample chamber; and a controller configured to receive input from said thermosensor, wherein said thermosensor provides feedback to heat or cool the TCE to set or maintain the solution at a desired temperature.
2. The thermal cycler system of claim 1, wherein said substrate is a biochip and wherein said sample chamber is a reaction chamber of said biochip.
3. An integrated biochip system comprising:
a biochip comprising:
(i) a cover layer having a thickness of less than 500 um; and (ii) at least one reaction chamber formed therein and further comprising a solution, each of said reaction chambers in contact with said cover layer and further comprising a microfluidic inlet channel and a microfluidic outlet channel; and (iii) at least one sensing chamber comprising a thermosensor, each of said sensing chambers fabricated to have the same material stack-up as the reaction chamber, and configured and positioned within the biochip at an analogous position to that of the solution in the reaction chamber so as to simulate the conditions within at least one reaction chamber; and a thermal cycler system, comprising:
a temperature control element (TCE) having a first surface,wherein the first surface of said TCE is in thermal communication with the cover layer of the biochip, and;
a controller configured to receive input from said thermosensor, said thermosensor providing feedback to heat or cool the TCE to set or maintain a desired temperature of the solution contained within said at least one reaction chamber.
CA2682761A 2007-04-04 2008-04-04 Methods for rapid multiplexed amplification of target nucleic acids Active CA2682761C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2894945A CA2894945C (en) 2007-04-04 2008-04-04 Methods for rapid multiplexed amplification of target nucleic acids

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US92180207P 2007-04-04 2007-04-04
US60/921,802 2007-04-04
US96450207P 2007-08-13 2007-08-13
US60/964,502 2007-08-13
US2807308P 2008-02-12 2008-02-12
US61/028,073 2008-02-12
PCT/US2008/004487 WO2008124116A1 (en) 2007-04-04 2008-04-04 Methods for rapid multiplexed amplification of target nucleic acids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2894945A Division CA2894945C (en) 2007-04-04 2008-04-04 Methods for rapid multiplexed amplification of target nucleic acids

Publications (2)

Publication Number Publication Date
CA2682761A1 CA2682761A1 (en) 2008-10-16
CA2682761C true CA2682761C (en) 2015-10-13

Family

ID=39591889

Family Applications (6)

Application Number Title Priority Date Filing Date
CA2984820A Active CA2984820C (en) 2007-04-04 2008-04-04 Plastic microfluidic separation and detection platforms
CA2682758A Active CA2682758C (en) 2007-04-04 2008-04-04 Integrated nucleic acid analysis
CA2682761A Active CA2682761C (en) 2007-04-04 2008-04-04 Methods for rapid multiplexed amplification of target nucleic acids
CA2682734A Active CA2682734C (en) 2007-04-04 2008-04-04 Plastic microfluidic separation and detection platforms
CA3135182A Active CA3135182C (en) 2007-04-04 2008-04-04 Plastic microfluidic separation and detection platforms
CA2894945A Active CA2894945C (en) 2007-04-04 2008-04-04 Methods for rapid multiplexed amplification of target nucleic acids

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CA2984820A Active CA2984820C (en) 2007-04-04 2008-04-04 Plastic microfluidic separation and detection platforms
CA2682758A Active CA2682758C (en) 2007-04-04 2008-04-04 Integrated nucleic acid analysis

Family Applications After (3)

Application Number Title Priority Date Filing Date
CA2682734A Active CA2682734C (en) 2007-04-04 2008-04-04 Plastic microfluidic separation and detection platforms
CA3135182A Active CA3135182C (en) 2007-04-04 2008-04-04 Plastic microfluidic separation and detection platforms
CA2894945A Active CA2894945C (en) 2007-04-04 2008-04-04 Methods for rapid multiplexed amplification of target nucleic acids

Country Status (9)

Country Link
US (12) US8425861B2 (en)
EP (7) EP3032251B1 (en)
JP (9) JP2010523115A (en)
KR (4) KR101523260B1 (en)
AU (5) AU2008236612B2 (en)
CA (6) CA2984820C (en)
ES (3) ES2748134T3 (en)
NZ (5) NZ602697A (en)
WO (4) WO2009011942A2 (en)

Families Citing this family (123)

* Cited by examiner, ā€  Cited by third party
Publication number Priority date Publication date Assignee Title
CN101073002B (en) 2004-09-15 2012-08-08 英ē‰¹åŸŗå› ęœ‰é™å…¬åø Microfluidic devices
GB0421529D0 (en) 2004-09-28 2004-10-27 Landegren Gene Technology Ab Microfluidic structure
WO2008030631A2 (en) * 2006-02-03 2008-03-13 Microchip Biotechnologies, Inc. Microfluidic devices
WO2008012550A2 (en) 2006-07-28 2008-01-31 Diagnostics For The Real World, Ltd. Device, system and method for processing a sample
EP2109666A4 (en) 2007-02-05 2011-09-14 Integenx Inc Microfluidic and nanofluidic devices, systems, and applications
ES2748134T3 (en) * 2007-04-04 2020-03-13 Ande Corp Systems for rapid multiple amplification of target nucleic acids
WO2009024773A1 (en) 2007-08-17 2009-02-26 Diagnostics For The Real World, Ltd Device, system and method for processing a sample
US20090253181A1 (en) * 2008-01-22 2009-10-08 Microchip Biotechnologies, Inc. Universal sample preparation system and use in an integrated analysis system
EP2280905B1 (en) 2008-04-11 2016-07-06 Fluidigm Corporation Multilevel microfluidic systems and methods
GB0818609D0 (en) 2008-10-10 2008-11-19 Univ Hull apparatus and method
CN102341691A (en) * 2008-12-31 2012-02-01 å°¹ē‰¹ę ¹åŸƒå…‹ę–Æęœ‰é™å…¬åø Instrument with microfluidic chip
US8058630B2 (en) * 2009-01-16 2011-11-15 Fluidigm Corporation Microfluidic devices and methods
NZ620826A (en) * 2009-02-03 2015-09-25 Netbio Inc Nucleic acid purification
US8388908B2 (en) 2009-06-02 2013-03-05 Integenx Inc. Fluidic devices with diaphragm valves
GB2483402B (en) 2009-06-04 2014-04-09 Lockheed Corp Multiple-sample microfluidic chip for DNA analysis
CA2764464A1 (en) 2009-06-05 2010-12-09 Integenx Inc. Universal sample preparation system and use in an integrated analysis system
US9550985B2 (en) 2009-06-15 2017-01-24 Netbio, Inc. Methods for forensic DNA quantitation
US8584703B2 (en) 2009-12-01 2013-11-19 Integenx Inc. Device with diaphragm valve
AU2011208946B2 (en) 2010-01-28 2014-10-02 Ellume Pty Ltd Sampling and testing device for the human or animal body
ITMI20100163A1 (en) * 2010-02-03 2011-08-04 Consiglio Nazionale Ricerche PROCEDURE FOR IDENTIFICATION AND TRACEABILITY OF PLANT COMPONENTS
AU2013204367A1 (en) * 2010-03-09 2013-05-16 Netbio, Inc. Unitary biochip providing sample-in to results-out processing and methods of manufacture
US8720036B2 (en) 2010-03-09 2014-05-13 Netbio, Inc. Unitary biochip providing sample-in to results-out processing and methods of manufacture
WO2011112746A2 (en) * 2010-03-09 2011-09-15 Netbio, Inc. Unitary biochip providing sample-in to results-out processing and methods of manufacture
JP5841315B2 (en) 2010-04-28 2016-01-13 ć‚½ćƒ‹ćƒ¼ę Ŗ式会ē¤¾ Fine particle analyzer
US8512538B2 (en) 2010-05-28 2013-08-20 Integenx Inc. Capillary electrophoresis device
US20110312793A1 (en) * 2010-06-17 2011-12-22 Geneasys Pty Ltd Microfluidic test module with low mass of probes
EP2606154B1 (en) 2010-08-20 2019-09-25 Integenx Inc. Integrated analysis system
US8763642B2 (en) 2010-08-20 2014-07-01 Integenx Inc. Microfluidic devices with mechanically-sealed diaphragm valves
US10114020B2 (en) * 2010-10-11 2018-10-30 Mbio Diagnostics, Inc. System and device for analyzing a fluidic sample
MX2013004184A (en) 2010-10-15 2013-07-29 Lockheed Corp Micro fluidic optic design.
EP2707509A4 (en) * 2011-05-12 2014-11-26 Netbio Inc Methods and compositions for rapid multiplex amplification of str loci
CA2835654A1 (en) 2011-06-01 2012-12-06 Streck, Inc. Rapid thermocycler system for rapid amplification of nucleic acids and related methods
US20130048487A1 (en) * 2011-08-25 2013-02-28 The University Of British Columbia Systems and methods for enrichment and detection of particles
US9207690B2 (en) * 2011-09-23 2015-12-08 Analogic Corporation Thermal cycling
US10865440B2 (en) 2011-10-21 2020-12-15 IntegenX, Inc. Sample preparation, processing and analysis systems
US20150136604A1 (en) 2011-10-21 2015-05-21 Integenx Inc. Sample preparation, processing and analysis systems
CN103160430A (en) 2011-12-13 2013-06-19 äø‰ę˜Ÿē”µå­ę Ŗ式会ē¤¾ Cell capturing filter having high aspect ratio
TWI470224B (en) * 2011-12-22 2015-01-21 Univ Chang Gung Detecting system and detecting method
US9322054B2 (en) 2012-02-22 2016-04-26 Lockheed Martin Corporation Microfluidic cartridge
JP6027321B2 (en) * 2012-03-06 2016-11-16 公ē›Šč²”å›£ę³•äŗŗē„žå„ˆå·ē§‘å­¦ęŠ€č”“ć‚¢ć‚«ćƒ‡ćƒŸćƒ¼ High-speed gene amplification detector
WO2013169915A1 (en) * 2012-05-08 2013-11-14 Brian Root Self-coating sieving copolymers and plastic devices for nucleic acid separations on such devices
KR102054678B1 (en) * 2012-07-12 2020-01-22 ģ‚¼ģ„±ģ „ģžģ£¼ģ‹ķšŒģ‚¬ Fluid analysis cartridge
CN104704357A (en) * 2012-07-30 2015-06-10 加利ē¦å°¼äŗšå¤§å­¦č‘£äŗ‹ä¼š Biomolecular detection test strip design
US20140200167A1 (en) 2012-08-01 2014-07-17 Nanomdx, Inc. Functionally integrated device for multiplex genetic identification
EP2883039A1 (en) 2012-08-10 2015-06-17 Streck Inc. Real-time optical system for polymerase chain reaction
US10890590B2 (en) 2012-09-27 2021-01-12 Ellume Limited Diagnostic devices and methods
US9739714B2 (en) 2012-10-29 2017-08-22 Mbio Diagnostics, Inc. Particle identification system, cartridge and associated methods
EP2932266A4 (en) 2012-12-17 2016-11-30 Leukodx Ltd Systems and methods for determining a chemical state
JP6257148B2 (en) * 2013-02-20 2018-01-10 ć‚­ćƒ¤ćƒŽćƒ³ę Ŗ式会ē¤¾ Image forming apparatus
RU2662932C2 (en) 2013-03-14 2018-07-31 ŠšŠ°Ń€ŠøŠ±Š¾ Š‘ŠøŠ¾ŃŠ°Š¹ŠµŠ½ŃŠøŠ·, Š˜Š½Šŗ. Compositions and methods with use of nucleic acids targeted at nucleic acids
US9146248B2 (en) 2013-03-14 2015-09-29 Intelligent Bio-Systems, Inc. Apparatus and methods for purging flow cells in nucleic acid sequencing instruments
US9591268B2 (en) 2013-03-15 2017-03-07 Qiagen Waltham, Inc. Flow cell alignment methods and systems
WO2014210593A1 (en) 2013-06-28 2014-12-31 Streck, Inc. Devices for real-time polymerase chain reaction
US9259823B2 (en) 2013-08-26 2016-02-16 Lawrence Livermore National Security, Llc Boron nitride composites
JP2015053893A (en) * 2013-09-11 2015-03-23 公ē›Šč²”å›£ę³•äŗŗē„žå„ˆå·ē§‘å­¦ęŠ€č”“ć‚¢ć‚«ćƒ‡ćƒŸćƒ¼ High-speed gene amplification detection device
JP6605454B2 (en) * 2013-09-24 2019-11-13 悶 ćƒŖćƒ¼ć‚øć‚§ćƒ³ćƒ„ ć‚Ŗ惖 悶 ćƒ¦ćƒ‹ćƒćƒ¼ć‚·ćƒ†ć‚£ ć‚Ŗ惖 ć‚«ćƒŖćƒ•ć‚©ćƒ«ćƒ‹ć‚¢ Generation of separation media using grayscale mask
WO2015073999A1 (en) 2013-11-18 2015-05-21 Integenx Inc. Cartridges and instruments for sample analysis
US9827566B2 (en) * 2013-11-19 2017-11-28 IDEA machine development design AND production ltd. Multi-well plates and methods of use thereof
US9630182B2 (en) 2013-12-04 2017-04-25 Leidos Innovations Technology, Inc. Non-contact infrared thermocycling
WO2015103326A1 (en) * 2013-12-31 2015-07-09 Canon U.S. Life Sciences, Inc. Field deployable small format fast first result microfluidic system
US20150203893A1 (en) * 2014-01-22 2015-07-23 Analogic Corporation Concurrently Evaluating Multiple Disease States Via Processing A Bio-Sample With A Single Multi-Channel Micro-Channel Device
US10195610B2 (en) 2014-03-10 2019-02-05 Click Diagnostics, Inc. Cartridge-based thermocycler
GB2526520B (en) * 2014-04-04 2021-08-18 It Is Int Ltd Biochemical reaction system
SG11201608600YA (en) 2014-04-14 2016-11-29 Stanford Res Inst Int Portable nucleic acid analysis system and high-performance microfluidic electroactive polymer actuators
WO2015179098A1 (en) 2014-05-21 2015-11-26 Integenx Inc. Fluidic cartridge with valve mechanism
CN105277725B (en) * 2014-07-01 2017-03-29 ęø…华大学 A kind of integrated micro-flow control system for foranalysis of nucleic acids detection
CN107106983B (en) * 2014-10-22 2021-04-16 å°¹ē‰¹ę ¹åŸƒå…‹ę–Æęœ‰é™å…¬åø Systems and methods for sample preparation, processing, and analysis
GB201419879D0 (en) 2014-11-07 2014-12-24 Ibm Self-limited, anisotropic wet etching of transverse vias in microfluidic chips
EP4029606A1 (en) 2014-12-31 2022-07-20 Visby Medical, Inc. Molecular diagnostic testing
EP3248001B1 (en) 2015-01-22 2019-09-18 Ellume Pty Ltd. Diagnostic devices and methods for mitigating hook effect and use thereof
GB2531616B (en) * 2015-02-02 2017-11-22 Atlas Genetics Ltd Instrument for performing a diagnostic test on a fluidic cartridge
DE112015005925B4 (en) * 2015-02-23 2023-06-15 Hitachi High-Tech Corporation Nucleic Acid Analyzer
EP3764093B1 (en) * 2015-05-20 2022-07-06 ProteinSimple System and methods for electrophoretic separation and analysis of analytes
US10233491B2 (en) 2015-06-19 2019-03-19 IntegenX, Inc. Valved cartridge and system
JP2017009435A (en) * 2015-06-22 2017-01-12 åÆŒå£«é›»ę©Ÿę Ŗ式会ē¤¾ Heating/cooling mechanism and heating/cooling system
KR101751913B1 (en) * 2015-09-08 2017-07-03 (ģ£¼) ķ•˜ģž„ė°”ģ“ģ˜¤ķ… A PCR-based point of care testing device coupled with electrophoretic microfluidic chip
CN108139354A (en) * 2015-09-22 2018-06-08 ē”Ÿē‰©č¾å°„实éŖŒå®¤č‚”ä»½ęœ‰é™å…¬åø Electrophoresis vessel and method
WO2017066485A1 (en) 2015-10-13 2017-04-20 Landers James P Devices and methods for extraction, separation and thermocycling
CN116083530A (en) * 2016-01-29 2023-05-09 ę™®ē‘žēē”Ÿē‰©ē³»ē»Ÿå…¬åø Isotachophoresis for nucleic acid purification
US20170282178A1 (en) * 2016-03-30 2017-10-05 Credo Biomedical Pte Ltd. Portable qpcr and qrt-pcr apparatus
US10987674B2 (en) 2016-04-22 2021-04-27 Visby Medical, Inc. Printed circuit board heater for an amplification module
WO2017197040A1 (en) 2016-05-11 2017-11-16 Click Diagnostics, Inc. Devices and methods for nucleic acid extraction
KR101913208B1 (en) * 2016-05-17 2018-10-30 ģšøģ‚°ėŒ€ķ•™źµ ģ‚°ķ•™ķ˜‘ė „ė‹Ø Extracting method of nucleic acid using solid phase object
CN106066303B (en) * 2016-05-24 2019-04-19 äø­å›½ē§‘学院重åŗ†ē»æč‰²ę™ŗčƒ½ęŠ€ęœÆē ”ē©¶é™¢ Biomolecule Terahertz characteristic signal receives runner prisms waveguide and preparation method thereof in a kind of enhancing solution
CN110325652A (en) 2016-06-29 2019-10-11 ę˜“ę·ä»Ŗå™ØčÆŠę–­č‚”ä»½ęœ‰é™å…¬åø Use the device and method of flow cell detection molecules
USD800331S1 (en) 2016-06-29 2017-10-17 Click Diagnostics, Inc. Molecular diagnostic device
USD800914S1 (en) 2016-06-30 2017-10-24 Click Diagnostics, Inc. Status indicator for molecular diagnostic device
USD800913S1 (en) 2016-06-30 2017-10-24 Click Diagnostics, Inc. Detection window for molecular diagnostic device
EP3269444A1 (en) * 2016-07-14 2018-01-17 Base4 Innovation Ltd Method of identifying droplets in a stack and an associated sequencer
DE102016222035A1 (en) * 2016-11-10 2018-05-17 Robert Bosch Gmbh Microfluidic device and method for analyzing samples
DE102017100189A1 (en) * 2017-01-06 2018-07-12 Technische UniversitƤt Braunschweig Method for two-dimensional protein separation and protein separation device
JP2020507344A (en) 2017-02-15 2020-03-12 ć‚¢ćƒ³ćƒ‡ć‚£ćƒ»ć‚³ćƒ¼ćƒćƒ¬ć‚¤ć‚·ćƒ§ćƒ³ļ¼”ļ¼®ļ¼¤ļ¼„ ļ¼£ļ½ļ½’ļ½ļ½ļ½’ļ½ļ½”ļ½‰ļ½ļ½Ž Systems and methods for rapid nucleic acid extraction, purification and analysis
US11602750B2 (en) * 2017-05-30 2023-03-14 Roche Molecular Systems, Inc. Customizable sample processing device
CA3069668A1 (en) 2017-07-12 2019-01-17 Ande Corporation Pattern recognition system
AU2018364741B2 (en) 2017-11-09 2021-03-25 Visby Medical, Inc. Portable molecular diagnostic device and methods for the detection of target viruses
KR102114148B1 (en) * 2018-01-03 2020-05-22 ģž¬ė‹Øė²•ģø źµ¬ėÆøģ „ģžģ •ė³“źø°ģˆ ģ› Method for Detecting Foodborne Microorganism
CN108220412B (en) * 2018-01-03 2021-10-01 äŗ¬äøœę–¹ē§‘ęŠ€é›†å›¢č‚”ä»½ęœ‰é™å…¬åø Gene sequencing substrate, preparation method thereof and gene sequencing device
US11150180B1 (en) * 2018-01-16 2021-10-19 Redshift Bioanalytics Inc. Actuated multi-chamber cells for fluid analysis
JP6937851B2 (en) * 2018-01-30 2021-09-22 äŗ¬ć‚»ćƒ©ę Ŗ式会ē¤¾ Measuring device
US10046322B1 (en) * 2018-03-22 2018-08-14 Talis Biomedical Corporation Reaction well for assay device
US20200347437A1 (en) * 2018-03-23 2020-11-05 Hewlett-Packard Development Company, L.P. Nucleic acid tests with temporal fluorescent signals
US11752500B2 (en) 2018-04-27 2023-09-12 Corning Incorporated Microfluidic devices and methods for manufacturing microfluidic devices
CN108645850A (en) * 2018-05-24 2018-10-12 ęƒ å·žę³•č·ÆęŗåŸŗ因ē§‘ęŠ€ęœ‰é™å…¬åø A kind of swab and its preparation method and application
US20220177980A1 (en) 2018-07-30 2022-06-09 Ande Corporation Multiplexed Fuel Analysis
DK3833466T3 (en) * 2018-08-06 2023-12-18 Siemens Healthcare Diagnostics Inc METHOD AND DEVICE FOR DETERMINING THE CONCENTRATION OF ANALYTES IN WHOLE BLOOD
WO2020033183A1 (en) * 2018-08-06 2020-02-13 Corning Incorporated Microfluidic devices and methods for manufacturing microfluidic devices
CN109813434B (en) * 2018-12-19 2020-07-10 厦é—Øčµ¢ē§‘å…‰ē”µęœ‰é™å…¬åø Human body identification method and device based on temperature detection and terminal equipment
US11684916B2 (en) * 2019-01-09 2023-06-27 Beijing Boe Optoelectronics Technology Co., Ltd. Chip for polymerase chain reaction, method of operation chip, and reaction device
RU2703776C9 (en) * 2019-01-25 2020-02-18 Š Š¾ŃŃŠøŠ¹ŃŠŗŠ°Ń Š¤ŠµŠ“ŠµŃ€Š°Ń†Šøя Š² Š»ŠøцŠµ ŠœŠøŠ½ŠøстŠµŃ€ŃŃ‚Š²Š° Š·Š“рŠ°Š²Š¾Š¾Ń…Ń€Š°Š½ŠµŠ½Šøя One-time chip for pcr analysis
JP6741100B2 (en) * 2019-02-28 2020-08-19 ć‚½ćƒ‹ćƒ¼ę Ŗ式会ē¤¾ Microparticle analyzer and microparticle analysis method
US20200299672A1 (en) * 2019-03-18 2020-09-24 Cellular Research, Inc. Precise delivery of components into fluids
US20220112453A1 (en) * 2019-04-30 2022-04-14 Hewlett-Packard Development Company, L.P. Cell lysis with a microbead and thermal resistor
US11352675B2 (en) 2020-01-03 2022-06-07 Visby Medical, Inc. Devices and methods for antibiotic susceptability testing
WO2021188877A1 (en) * 2020-03-19 2021-09-23 Mayo Foundation For Medical Education And Research Point-of-care digital microfluidics for sepsis diagnosis
KR102288369B1 (en) * 2020-12-23 2021-08-10 ģ£¼ģ‹ķšŒģ‚¬ ėÆøģ½”ė°”ģ“ģ˜¤ė©”ė“œ Integrated chip with lysis and amplifying nucleic acids, lysis module having the same, apparatus for point-of-care-testing having the same, and method for lysis and amplifying nucleic acids using the same
CN112782395B (en) 2020-12-30 2021-11-09 北äŗ¬äø­ē§‘ē”Ÿä»Ŗē§‘ęŠ€ęœ‰é™å…¬åø PCR detector and method thereof
CN113278509B (en) * 2021-01-15 2022-04-26 北äŗ¬äø­ē§‘ē”Ÿä»Ŗē§‘ęŠ€ęœ‰é™å…¬åø Chip device for nucleic acid detection
CN112903613B (en) * 2021-02-24 2022-11-08 å—ę˜Œå¤§å­¦ Labview-based transient absorption spectrum control system design method
WO2023019105A1 (en) * 2021-08-08 2023-02-16 Keydev Inc. Cartridge gel electrophoresis device for separating biomolecules
CN113702317B (en) * 2021-08-30 2023-10-27 äø­å›½å†œäøšē§‘学院农äøšäæ”ęÆē ”ē©¶ę‰€ River basin non-point source pollution component sensor, monitoring system and method
CN114231401B (en) * 2022-02-21 2022-05-03 北äŗ¬čŠÆčæˆå¾®ē”Ÿē‰©ęŠ€ęœÆęœ‰é™å…¬åø Nucleic acid detection kit and detection method
WO2023168085A1 (en) * 2022-03-04 2023-09-07 Catalog Technologies, Inc. Dna microarrays and component level sequencing for nucleic acid-based data storage and processing
KR20230155183A (en) * 2022-05-03 2023-11-10 ź²½ė¶ėŒ€ķ•™źµ ģ‚°ķ•™ķ˜‘ė „ė‹Ø A portable device for isolationg nucleic acids in blood

Family Cites Families (292)

* Cited by examiner, ā€  Cited by third party
Publication number Priority date Publication date Assignee Title
US2817264A (en) 1953-10-19 1957-12-24 Beckman Instruments Inc Electrophoresis apparatus
US4170616A (en) 1978-05-30 1979-10-09 Rca Corporation Method of fabrication of a Fresnel lens
US5821058A (en) 1984-01-16 1998-10-13 California Institute Of Technology Automated DNA sequencing technique
US5171534A (en) 1984-01-16 1992-12-15 California Institute Of Technology Automated DNA sequencing technique
US5038852A (en) * 1986-02-25 1991-08-13 Cetus Corporation Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps
DE3531570A1 (en) * 1985-09-04 1987-03-05 Glotur Trust IGNITION DEVICE FOR INTERNAL COMBUSTION ENGINES
US4855225A (en) 1986-02-07 1989-08-08 Applied Biosystems, Inc. Method of detecting electrophoretically separated oligonucleotides
US4811218A (en) * 1986-06-02 1989-03-07 Applied Biosystems, Inc. Real time scanning electrophoresis apparatus for DNA sequencing
CA1340806C (en) * 1986-07-02 1999-11-02 James Merrill Prober Method, system and reagents for dna sequencing
US5112460A (en) * 1986-10-21 1992-05-12 Northeastern University High performance microcapillary gel electrophoresis
US4865707A (en) 1986-10-21 1989-09-12 Northeastern University Capillary gel electrophoresis columns
JPH0799353B2 (en) * 1987-03-31 1995-10-25 ę Ŗ式会ē¤¾å³¶ę“„č£½ä½œę‰€ Nucleotide sequencer
JP2550106B2 (en) * 1987-10-30 1996-11-06 ę Ŗ式会ē¤¾ę—„ē«‹č£½ä½œę‰€ Optical dispersion detection type electrophoretic device
GB8807297D0 (en) * 1988-03-26 1988-04-27 Dean P D G Intelligent heating block
US4945135A (en) * 1988-07-25 1990-07-31 California Institute Of Technology Ring opening metathesis polymerization of strained cyclic ethers
US5281516A (en) 1988-08-02 1994-01-25 Gene Tec Corporation Temperature control apparatus and method
CA1339731C (en) 1988-10-12 1998-03-17 Charles T. Caskey Multiplex genomic dna amplification for deletion detection
US5234809A (en) 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
FR2654552A1 (en) * 1989-11-14 1991-05-17 Radiotechnique Compelec SEGMENTED PHOTOMULTIPLIER TUBE WITH HIGH COLLECTION EFFICIENCY AND LIMITED DIAPHYT.
US5164055A (en) 1990-01-29 1992-11-17 Applied Biosystems, Inc. High-viscosity polymer matrix and methods
US5126022A (en) * 1990-02-28 1992-06-30 Soane Tecnologies, Inc. Method and device for moving molecules by the application of a plurality of electrical fields
US5858188A (en) * 1990-02-28 1999-01-12 Aclara Biosciences, Inc. Acrylic microchannels and their use in electrophoretic applications
US5750015A (en) * 1990-02-28 1998-05-12 Soane Biosciences Method and device for moving molecules by the application of a plurality of electrical fields
US5770029A (en) * 1996-07-30 1998-06-23 Soane Biosciences Integrated electrophoretic microdevices
US5307148A (en) * 1990-04-05 1994-04-26 Hitachi, Ltd. Fluorescence detection type electrophoresis apparatus
JP2826366B2 (en) * 1990-04-12 1998-11-18 ę Ŗ式会ē¤¾ę—„ē«‹č£½ä½œę‰€ Fluorescence detection type electrophoresis device
US5085756A (en) * 1990-08-21 1992-02-04 Hewlett-Packard Company Column separation system for electrophoresis with sample pretreatment
KR100236506B1 (en) * 1990-11-29 2000-01-15 ķ¼ķ‚Ø-ģ—˜ėØøģ‹œķ„°ģŠ¤ģøģŠ¤ķŠøė£Øėؼģø  Apparatus for polymerase chain reaction
US5332481A (en) * 1991-01-29 1994-07-26 Beckman Instruments, Inc. Capillary electrophoresis using replaceable gels
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
WO1992022590A1 (en) 1991-06-11 1992-12-23 Nippon Zeon Co., Ltd. Hydrogenated thermoplastic norbornene polymer, production thereof, and optical element base, optical element and lens molded therefrom
US5334424A (en) 1991-06-17 1994-08-02 Nippon Zeon Co., Ltd. Thermoplastic norbornene resin formed articles and sustrates for liquid crystal display
US5273638A (en) * 1991-09-30 1993-12-28 Beckman Instruments, Inc. Nucleotide sequence determination employing matched dideoxynucleotide terminator concentrations
US5274602A (en) * 1991-10-22 1993-12-28 Florida Atlantic University Large capacity solid-state memory
US5198511A (en) * 1991-12-20 1993-03-30 Minnesota Mining And Manufacturing Company Polymerizable compositions containing olefin metathesis catalysts and cocatalysts, and methods of use therefor
US5468803A (en) 1992-03-03 1995-11-21 Nippon Zeon Co. Ltd. Medical implement, polymer composition, and optical material
WO1993019205A1 (en) * 1992-03-19 1993-09-30 The Regents Of The University Of California Multiple tag labeling method for dna sequencing
US5312940A (en) 1992-04-03 1994-05-17 California Institute Of Technology Ruthenium and osmium metal carbene complexes for olefin metathesis polymerization
US5587128A (en) 1992-05-01 1996-12-24 The Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification devices
US5290418A (en) * 1992-09-24 1994-03-01 Applied Biosystems, Inc. Viscous electrophoresis polymer medium and method
CA2110463C (en) * 1992-12-17 2005-02-08 Jacob Emert Gel-free ethylene interpolymer dispersant additives useful in oleaginous compositions
US5364790A (en) 1993-02-16 1994-11-15 The Perkin-Elmer Corporation In situ PCR amplification system
EP1296134B1 (en) 1993-04-15 2013-05-29 Bayer Intellectual Property GmbH Sampling device and its use for controlling sample introduction in microcolumn separation techniques
EP0635994B1 (en) * 1993-07-08 1998-09-23 Canon Kabushiki Kaisha Method and apparatus for separating particles
US5925517A (en) 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
US6403367B1 (en) 1994-07-07 2002-06-11 Nanogen, Inc. Integrated portable biological detection system
US5840338A (en) 1994-07-18 1998-11-24 Roos; Eric J. Loading of biologically active solutes into polymer gels
US6001229A (en) * 1994-08-01 1999-12-14 Lockheed Martin Energy Systems, Inc. Apparatus and method for performing microfluidic manipulations for chemical analysis
US5596226A (en) * 1994-09-06 1997-01-21 International Business Machines Corporation Semiconductor chip having a chip metal layer and a transfer metal and corresponding electronic module
US7008771B1 (en) 1994-09-30 2006-03-07 Promega Corporation Multiplex amplification of short tandem repeat loci
US6479235B1 (en) * 1994-09-30 2002-11-12 Promega Corporation Multiplex amplification of short tandem repeat loci
US5843660A (en) * 1994-09-30 1998-12-01 Promega Corporation Multiplex amplification of short tandem repeat loci
CA2118048C (en) 1994-09-30 2003-04-08 James W. Schumm Multiplex amplification of short tandem repeat loci
US6017434A (en) * 1995-05-09 2000-01-25 Curagen Corporation Apparatus and method for the generation, separation, detection, and recognition of biopolymer fragments
US6485625B1 (en) * 1995-05-09 2002-11-26 Curagen Corporation Apparatus and method for the generation, separation, detection, and recognition of biopolymer fragments
US5882856A (en) * 1995-06-07 1999-03-16 Genzyme Corporation Universal primer sequence for multiplex DNA amplification
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US5994066A (en) 1995-09-11 1999-11-30 Infectio Diagnostic, Inc. Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US20020068357A1 (en) * 1995-09-28 2002-06-06 Mathies Richard A. Miniaturized integrated nucleic acid processing and analysis device and method
US6709869B2 (en) 1995-12-18 2004-03-23 Tecan Trading Ag Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system
US5830657A (en) * 1996-05-01 1998-11-03 Visible Genetics Inc. Method for single-tube sequencing of nucleic acid polymers
US5723294A (en) * 1996-03-05 1998-03-03 Gull Laboratories Methods for detection and discrimination of multiple analytes using fluorescent technology
AU713667B2 (en) 1996-04-12 1999-12-09 Phri Properties, Inc. Detection probes, kits and assays
US5885470A (en) * 1997-04-14 1999-03-23 Caliper Technologies Corporation Controlled fluid transport in microfabricated polymeric substrates
US5942443A (en) 1996-06-28 1999-08-24 Caliper Technologies Corporation High throughput screening assay systems in microscale fluidic devices
US6706875B1 (en) * 1996-04-17 2004-03-16 Affyemtrix, Inc. Substrate preparation process
US5994064A (en) 1996-04-24 1999-11-30 Identigene, Inc. Simple and complex tandem repeats with DNA typing method
US5847162A (en) 1996-06-27 1998-12-08 The Perkin Elmer Corporation 4, 7-Dichlororhodamine dyes
US5800996A (en) 1996-05-03 1998-09-01 The Perkin Elmer Corporation Energy transfer dyes with enchanced fluorescence
WO1997043611A1 (en) * 1996-05-16 1997-11-20 Affymetrix, Inc. Systems and methods for detection of labeled materials
US6156512A (en) 1996-05-23 2000-12-05 Promega Corp Allelic ladders for short tandem repeat loci
US6361672B1 (en) * 1996-06-10 2002-03-26 Transgenomic, Inc. Multiple laser diode electromagnetic radiation source in multiple electrophoresis channel systems
BR9710054A (en) 1996-06-28 2000-01-11 Caliper Techn Corp Apparatus for separating test compounds for an effect on a biochemical system and for detecting a effect of a test compound on a biochemical system, procedures for determining whether a sample contains a compound capable of affecting a biochemical system, for separating a plurality of test compounds for an effect on a biochemical system and uses of a microfluidic system and a test substrate.
US5779868A (en) * 1996-06-28 1998-07-14 Caliper Technologies Corporation Electropipettor and compensation means for electrophoretic bias
US5858187A (en) * 1996-09-26 1999-01-12 Lockheed Martin Energy Systems, Inc. Apparatus and method for performing electrodynamic focusing on a microchip
WO1998017992A2 (en) * 1996-10-25 1998-04-30 Applied Imaging, Inc. Multifluor-fluorescence in situ hybridization (m-fish) imaging techniques using multiple multiband filters with image registration
US6372142B1 (en) * 1996-11-13 2002-04-16 Transgenomic, Inc. Column for DNA separation by matched ion polynucleotide chromatography
US6312886B1 (en) 1996-12-06 2001-11-06 The Secretary Of State For Defence In Her Brittanic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Reaction vessels
EP0854362A3 (en) 1997-01-16 2000-12-20 Japan Science and Technology Corporation Multi-capillary electrophoresis apparatus
JPH10239278A (en) * 1997-02-24 1998-09-11 Hitachi Ltd Cataphoresis device
US6074868A (en) 1997-03-03 2000-06-13 Regents Of The University Of Minnesota Alumina plate method and device for controlling temperature
US6391622B1 (en) * 1997-04-04 2002-05-21 Caliper Technologies Corp. Closed-loop biochemical analyzers
JP2001521394A (en) 1997-04-22 2001-11-06 惐惐ćƒŖć‚¢ćƒ³ćƒ»ćƒŽćƒ«ćƒ‡ć‚£ćƒƒć‚Æ惻ćƒŖć‚µćƒ¼ćƒćƒ»ć‚¤ćƒ³ć‚¹ćƒ†ć‚£ćƒ†ćƒ„ćƒ¼ćƒˆćƒ»ć‚¢ć‚Æćƒ†ć‚£ćƒ¼ć‚¼ćƒ«ć‚¹ć‚«ćƒ– TaqMan ā„¢ upper TM ā„¢ -PCR for detection of pathogenic E. coli strains
DE19717085C2 (en) 1997-04-23 1999-06-17 Bruker Daltonik Gmbh Processes and devices for extremely fast DNA multiplication using polymerase chain reactions (PCR)
KR100351531B1 (en) 1997-04-25 2002-09-11 ģŗ˜ė¦¬ķ¼ ķ…Œķ¬ė†€ė”œģ§€ģŠ¤ ģ½”ķ¬ė ˆģ“ģ…˜ Microfludic devices incorporating improved channel geometries
US7033474B1 (en) * 1997-04-25 2006-04-25 Caliper Life Sciences, Inc. Microfluidic devices incorporating improved channel geometries
US5976336A (en) * 1997-04-25 1999-11-02 Caliper Technologies Corp. Microfluidic devices incorporating improved channel geometries
US6410275B1 (en) 1997-05-02 2002-06-25 Biomerieux, Inc. Disposable test devices for performing nucleic acid amplification reactions
US5989499A (en) 1997-05-02 1999-11-23 Biomerieux, Inc. Dual chamber disposable reaction vessel for amplification reactions
US6429007B1 (en) 1997-05-02 2002-08-06 BIOMĆ©RIEUX, INC. Nucleic acid amplification reaction station for disposable test devices
US5786182A (en) 1997-05-02 1998-07-28 Biomerieux Vitek, Inc. Dual chamber disposable reaction vessel for amplification reactions, reaction processing station therefor, and methods of use
US6632619B1 (en) * 1997-05-16 2003-10-14 The Governors Of The University Of Alberta Microfluidic system and methods of use
JP3469585B2 (en) 1997-05-23 2003-11-25 ć‚¬ćƒ”ćƒ© 惐悤ć‚Ŗ悵悤ć‚Øćƒ³ć‚¹ ć‚³ćƒ¼ćƒćƒ¬ć‚¤ć‚·ćƒ§ćƒ³ Apparatus and method for using centripetal acceleration to drive flow motion in microfluidics systems
US5876675A (en) * 1997-08-05 1999-03-02 Caliper Technologies Corp. Microfluidic devices and systems
US6207031B1 (en) 1997-09-15 2001-03-27 Whitehead Institute For Biomedical Research Methods and apparatus for processing a sample of biomolecular analyte using a microfabricated device
AU1517999A (en) 1997-10-15 1999-05-03 Aclara Biosciences, Inc. Laminate microstructure device and method for making same
US6143152A (en) 1997-11-07 2000-11-07 The Regents Of The University Of California Microfabricated capillary array electrophoresis device and method
EP1179585B1 (en) * 1997-12-24 2008-07-09 Cepheid Device and method for lysis
US6826524B1 (en) 1998-01-08 2004-11-30 Purdue Research Foundation Sample-adaptive product quantization
US6167910B1 (en) * 1998-01-20 2001-01-02 Caliper Technologies Corp. Multi-layer microfluidic devices
US6857449B1 (en) * 1998-01-20 2005-02-22 Caliper Life Sciences, Inc. Multi-layer microfluidic devices
US6080868A (en) * 1998-01-23 2000-06-27 The Perkin-Elmer Corporation Nitro-substituted non-fluorescent asymmetric cyanine dye compounds
US6210882B1 (en) * 1998-01-29 2001-04-03 Mayo Foundation For Medical Education And Reseach Rapid thermocycling for sample analysis
US6420143B1 (en) 1998-02-13 2002-07-16 Caliper Technologies Corp. Methods and systems for performing superheated reactions in microscale fluidic systems
US6100541A (en) 1998-02-24 2000-08-08 Caliper Technologies Corporation Microfluidic devices and systems incorporating integrated optical elements
CA2230653A1 (en) 1998-02-27 1999-08-27 The Governors Of The University Of Alberta Microchip based enzymatic analysis
US6251247B1 (en) * 1998-04-01 2001-06-26 Hitachi Chemical Co., Ltd. Detection of degradation of RNA using microchannel electrophoresis
US6200531B1 (en) * 1998-05-11 2001-03-13 Igen International, Inc. Apparatus for carrying out electrochemiluminescence test measurements
US6172997B1 (en) 1998-06-16 2001-01-09 Aculight Corporation Integrated semiconductor diode laser pumped solid state laser
WO2000009758A1 (en) 1998-08-14 2000-02-24 The Regents Of The University Of California NOVEL AMPLICON IN THE 20q13 REGION OF HUMAN CHROMOSOME 20 AND USES THEREOF
US6605472B1 (en) 1998-10-09 2003-08-12 The Governors Of The University Of Alberta Microfluidic devices connected to glass capillaries with minimal dead volume
JP3613032B2 (en) * 1998-10-26 2005-01-26 ę Ŗ式会ē¤¾ę—„ē«‹č£½ä½œę‰€ Capillary array electrophoresis device
DE19856064C2 (en) 1998-12-04 2000-11-30 Invitek Gmbh Universal method for the isolation of DNA from any starting material
US6431476B1 (en) * 1999-12-21 2002-08-13 Cepheid Apparatus and method for rapid ultrasonic disruption of cells or viruses
US6261431B1 (en) 1998-12-28 2001-07-17 Affymetrix, Inc. Process for microfabrication of an integrated PCR-CE device and products produced by the same
US7261859B2 (en) * 1998-12-30 2007-08-28 Gyros Ab Microanalysis device
US6249341B1 (en) * 1999-01-25 2001-06-19 Amnis Corporation Imaging and analyzing parameters of small moving objects such as cells
CA2297352A1 (en) 1999-02-05 2000-08-05 Robert J. Lipshutz Multiplex genotyping of populations of individuals
US6558945B1 (en) * 1999-03-08 2003-05-06 Aclara Biosciences, Inc. Method and device for rapid color detection
US6225061B1 (en) * 1999-03-10 2001-05-01 Sequenom, Inc. Systems and methods for performing reactions in an unsealed environment
US6303343B1 (en) 1999-04-06 2001-10-16 Caliper Technologies Corp. Inefficient fast PCR
US6235479B1 (en) * 1999-04-13 2001-05-22 Bio Merieux, Inc. Methods and devices for performing analysis of a nucleic acid sample
US20050181440A1 (en) 1999-04-20 2005-08-18 Illumina, Inc. Nucleic acid sequencing using microsphere arrays
JP3597729B2 (en) * 1999-05-11 2004-12-08 ę—„ē«‹ć‚½ćƒ•ćƒˆć‚¦ć‚Øć‚¢ć‚Øćƒ³ć‚øćƒ‹ć‚¢ćƒŖćƒ³ć‚°ę Ŗ式会ē¤¾ Fluorescence metering method and fluorescence meter
AU782343B2 (en) 1999-05-28 2005-07-21 Cepheid Apparatus and method for analyzing a fluid sample
US6472155B1 (en) 1999-06-08 2002-10-29 The Regents Of The University Of California Species specific identification of spore-producing microbes using the gene sequence of small acid-soluble spore coat proteins for amplification based diagnostics
US6706519B1 (en) * 1999-06-22 2004-03-16 Tecan Trading Ag Devices and methods for the performance of miniaturized in vitro amplification assays
US6664104B2 (en) * 1999-06-25 2003-12-16 Cepheid Device incorporating a microfluidic chip for separating analyte from a sample
GB9917307D0 (en) * 1999-07-23 1999-09-22 Sec Dep Of The Home Department Improvements in and relating to analysis of DNA
US6864050B2 (en) * 1999-07-30 2005-03-08 Affymetrix, Inc. Single-phase amplification of nucleic acids
US6472156B1 (en) * 1999-08-30 2002-10-29 The University Of Utah Homogeneous multiplex hybridization analysis by color and Tm
US6633785B1 (en) 1999-08-31 2003-10-14 Kabushiki Kaisha Toshiba Thermal cycler and DNA amplifier method
GB9922971D0 (en) 1999-09-29 1999-12-01 Secr Defence Reaction system
DE19947495C2 (en) 1999-10-01 2003-05-28 Agilent Technologies Inc Microfluidic microchip
US6630063B1 (en) 1999-10-06 2003-10-07 I. Reich Family Limited Partnership Uniform laser excitation and detection in capillary array electrophoresis system and method
ATE408141T1 (en) 1999-10-20 2008-09-15 Shigeori Takenaka GENE DETECTION CHIP, SENSOR AND DETECTION METHOD
US6471916B1 (en) * 1999-11-09 2002-10-29 Packard Instrument Company Apparatus and method for calibration of a microarray scanning system
US6875619B2 (en) 1999-11-12 2005-04-05 Motorola, Inc. Microfluidic devices comprising biochannels
CA2290731A1 (en) 1999-11-26 2001-05-26 D. Jed Harrison Apparatus and method for trapping bead based reagents within microfluidic analysis system
US6432290B1 (en) 1999-11-26 2002-08-13 The Governors Of The University Of Alberta Apparatus and method for trapping bead based reagents within microfluidic analysis systems
US6497977B1 (en) * 1999-11-30 2002-12-24 Ballard Power Systems Inc. Method of making stripped porous polymer films
CA2393690A1 (en) * 1999-12-09 2001-06-14 Huinan Yu Multilayered microfluidic devices for analyte reactions
US6884395B2 (en) 2000-05-12 2005-04-26 Gyros Ab Integrated microfluidic disc
ATE412774T1 (en) * 2000-02-16 2008-11-15 Illumina Inc PARALLEL GENOTYPING OF MULTIPLE PATIENT SAMPLES
US6407395B1 (en) * 2000-02-29 2002-06-18 The University Of Chicago Portable biochip scanner device
US6329661B1 (en) * 2000-02-29 2001-12-11 The University Of Chicago Biochip scanner device
ITCA20000004A1 (en) 2000-03-07 2001-09-07 Mario Raimondo Caria METHOD AND SYSTEM FOR SIMULTANEOUS AND MULTIPLE DETECTION WITH QUANTIFICATION OF THE HYBRIDIZATION OF MOLECULAR COMPOUNDS SUCH AS CORE ACIDS
US8288128B2 (en) * 2004-11-18 2012-10-16 Eppendorf Array Technologies S.A. Real-time quantification of multiple targets on a micro-array
US6358387B1 (en) * 2000-03-27 2002-03-19 Caliper Technologies Corporation Ultra high throughput microfluidic analytical systems and methods
EP1142544B1 (en) * 2000-04-04 2008-03-26 Link Spine Group, Inc. Intervertebral implant
US6734420B2 (en) 2000-04-06 2004-05-11 Quantum Dot Corporation Differentiable spectral bar code methods and systems
US7306924B2 (en) 2000-04-17 2007-12-11 Purdue Research Foundation Biosensor and related method
US6733645B1 (en) * 2000-04-18 2004-05-11 Caliper Technologies Corp. Total analyte quantitation
US6448014B2 (en) 2000-04-19 2002-09-10 Research Development Foundation PCR-hybridization assays specific for integrated retroviruses
US6787016B2 (en) * 2000-05-01 2004-09-07 Aclara Biosciences, Inc. Dynamic coating with linear polymer mixture for electrophoresis
US6777184B2 (en) * 2000-05-12 2004-08-17 Caliper Life Sciences, Inc. Detection of nucleic acid hybridization by fluorescence polarization
AU2001259770A1 (en) 2000-05-15 2001-11-26 Biomicro Systems, Inc. Air flow regulation in microfluidic circuits for pressure control and gaseous exchange
US6635487B1 (en) * 2000-05-17 2003-10-21 Caliper Technologies Corp. Fluorescence standard for use in microfluidic instruments
US6531282B1 (en) 2000-05-30 2003-03-11 Oligotrail, Llc Multiplex amplification and analysis of selected STR loci
CA2352639A1 (en) * 2000-07-14 2002-01-14 John Joseph Cullen A method and apparatus for monitoring a condition in chlorophyll containing matter
JP4896349B2 (en) * 2000-07-21 2012-03-14 ć‚¢ć‚Æ惩惩 惐悤ć‚Ŗ悵悤ć‚Øćƒ³ć‚·ćƒ¼ć‚ŗļ¼Œ ć‚¤ćƒ³ć‚³ćƒ¼ćƒćƒ¬ć‚¤ćƒ†ćƒƒćƒ‰ Methods and devices for capillary electrophoresis using a norbornene-based surface coating.
US7008769B2 (en) * 2000-08-15 2006-03-07 Bioforce Nanosciences, Inc. Nanoscale molecular arrayer
WO2002018660A2 (en) 2000-08-31 2002-03-07 Mayo Foundation For Medical Education And Research Detection of varicella-zoster virus
DE50012114D1 (en) * 2000-09-05 2006-04-13 Zeltz Patrick Method for the specific determination of DNA sequences by means of parallel amplification
US6939451B2 (en) 2000-09-19 2005-09-06 Aclara Biosciences, Inc. Microfluidic chip having integrated electrodes
US6482641B2 (en) * 2000-10-02 2002-11-19 Boris Chen DNA-based integrated circuit
US7150815B2 (en) 2000-10-05 2006-12-19 E. I. Du Pont De Nemours And Company Polymeric microfabricated fluidic device suitable for ultraviolet detection
WO2002035223A1 (en) * 2000-10-25 2002-05-02 Xiamen University Electrophoretic separating device and method for using the device
US7033475B2 (en) * 2000-10-25 2006-04-25 Shimadzu Corporation Electrophoretic apparatus
WO2002061387A2 (en) 2000-10-25 2002-08-08 Exiqon A/S Open substrate platforms suitable for analysis of biomolecules
US6824024B2 (en) 2000-11-17 2004-11-30 Tecan Trading Ag Device for the take-up and/or release of liquid samples
JP3663125B2 (en) 2000-11-28 2005-06-22 ę—„ē«‹ć‚½ćƒ•ćƒˆć‚¦ć‚Øć‚¢ć‚Øćƒ³ć‚øćƒ‹ć‚¢ćƒŖćƒ³ć‚°ę Ŗ式会ē¤¾ Fluorescence reading method and fluorescence reading apparatus
US6630680B2 (en) * 2000-12-25 2003-10-07 Fuji Photo Film Co., Ltd. Scanner having confocal optical system, method for producing focus position data of confocal optical system of scanner having confocal optical system and method for producing digital data of scanner having confocal optical system
US6800438B2 (en) * 2000-12-28 2004-10-05 Xerox Corporation Imager for DNA sequencer
WO2002056004A2 (en) 2001-01-12 2002-07-18 Syngenta Participations Ag Thin film electrophoresis apparatus and method
ES2344594T3 (en) 2001-01-31 2010-09-01 Mayo Foundation For Medical Education And Research DETECTION OF THE SIMPLEX HERPES VIRUS.
WO2002063288A1 (en) 2001-01-31 2002-08-15 Sau Lan Tang Staats Microfluidic devices
CA2438130A1 (en) 2001-02-13 2002-08-22 Children's Hospital Research Foundation Quantitative epstein barr virus pcr rapid assay
EP2089413A4 (en) 2001-02-21 2009-10-28 Amnis Corp Method and apparatus for labeling and analyzing cellular components
DE10111457B4 (en) 2001-03-09 2006-12-14 Siemens Ag diagnostic device
DE10116674C2 (en) 2001-04-04 2003-08-14 Eppendorf Ag Device for the detection of fluids in a microfluidic component
US6598545B2 (en) 2001-04-10 2003-07-29 Newport Corporation Vibration damper for optical tables and other structures
DK1392814T3 (en) 2001-04-25 2007-09-24 Cornell Res Foundation Inc Devices and Methods for Pharmacokinetic Based Cell Culture System
FR2823999B1 (en) 2001-04-27 2003-06-27 Commissariat Energie Atomique MINIATURE DEVICE FOR SEPARATING AND ISOLATING BIOLOGICAL OBJECTS AND USES
US6929730B2 (en) * 2001-05-01 2005-08-16 Cheng Sheng Lee Two dimensional microfluidic gene scanner
US6596140B2 (en) * 2001-05-01 2003-07-22 Applera Corporation Multi-channel capillary electrophoresis device and method
US20030007895A1 (en) * 2001-06-19 2003-01-09 Fuji Photo Film Co., Ltd. Biochemical analysis unit
US7179423B2 (en) 2001-06-20 2007-02-20 Cytonome, Inc. Microfluidic system including a virtual wall fluid interface port for interfacing fluids with the microfluidic system
US6762049B2 (en) * 2001-07-05 2004-07-13 Institute Of Microelectronics Miniaturized multi-chamber thermal cycler for independent thermal multiplexing
WO2003004982A1 (en) * 2001-07-05 2003-01-16 Hamamatsu Photonics K.K. Spectroscopic device
JP2003028797A (en) * 2001-07-11 2003-01-29 Hitachi Software Eng Co Ltd Fluorescence reader
US20030021016A1 (en) * 2001-07-27 2003-01-30 Grier David G. Parallel scanned laser confocal microscope
US20040175299A1 (en) * 2001-08-03 2004-09-09 Alexei Belenky Microscale affinity purification system
US6919058B2 (en) 2001-08-28 2005-07-19 Gyros Ab Retaining microfluidic microcavity and other microfluidic structures
US6995841B2 (en) * 2001-08-28 2006-02-07 Rice University Pulsed-multiline excitation for color-blind fluorescence detection
US6617137B2 (en) 2001-10-15 2003-09-09 Molecular Staging Inc. Method of amplifying whole genomes without subjecting the genome to denaturing conditions
DE60235485D1 (en) 2001-10-15 2010-04-08 Nissin Foods Holdings Co Ltd PRIMER AND METHOD FOR DETECTING BACTERIA
WO2003044221A1 (en) 2001-10-19 2003-05-30 West Virginia University Research Corporation Microfluidic system for proteome analysis
US7069952B1 (en) 2001-11-14 2006-07-04 Caliper Life Sciences, Inc. Microfluidic devices and methods of their manufacture
US6960298B2 (en) 2001-12-10 2005-11-01 Nanogen, Inc. Mesoporous permeation layers for use on active electronic matrix devices
JP3537802B2 (en) * 2001-12-18 2004-06-14 ę Ŗ式会ē¤¾ę—„ē«‹č£½ä½œę‰€ Electrophoresis chip
JP2003180350A (en) 2001-12-21 2003-07-02 Terumo Corp Temperature control device
JP2003194775A (en) 2001-12-28 2003-07-09 Japan Science & Technology Corp Electrophoresis method of protein
US7141372B2 (en) 2002-01-18 2006-11-28 Health Research Incorporated Universal RT-coupled PCR method for the specific amplification of mRNA
US7846315B2 (en) * 2002-01-28 2010-12-07 Qiagen Sciences, Llc Integrated bio-analysis and sample preparation system
US20040109793A1 (en) * 2002-02-07 2004-06-10 Mcneely Michael R Three-dimensional microfluidics incorporating passive fluid control structures
US20030155966A1 (en) 2002-02-20 2003-08-21 Harrison Reid R. Low-power, low-noise CMOS amplifier
DE10208770A1 (en) 2002-02-28 2003-09-04 Febit Ag Increasing the sensitivity and specificity of hybridization experiments with nucleic acid chips
KR100459896B1 (en) 2002-03-06 2004-12-04 ģ‚¼ģ„±ģ „ģžģ£¼ģ‹ķšŒģ‚¬ Thermostatic control Method and apparatus for Driving a PCR(polymerize chain reaction) chip
JP2003271735A (en) 2002-03-12 2003-09-26 Yokogawa Electric Corp Gene diagnosing and analyzing device, and gene diagnosis support system using the same
WO2003078586A2 (en) 2002-03-12 2003-09-25 The Regents Of The University Of California Vascularized tissue for transplantation
US7419784B2 (en) * 2002-04-02 2008-09-02 Dubrow Robert S Methods, systems and apparatus for separation and isolation of one or more sample components of a sample biological material
US6606273B1 (en) 2002-04-11 2003-08-12 Advanced Micro Devices, Inc. Methods and systems for flash memory tunnel oxide reliability testing
US20040009518A1 (en) * 2002-05-14 2004-01-15 The Chinese University Of Hong Kong Methods for evaluating a disease condition by nucleic acid detection and fractionation
JP2006501860A (en) * 2002-05-22 2006-01-19 ćƒ—ćƒ©ćƒ†ć‚£ćƒ‘ć‚¹ 惆ć‚Æ惎惭ć‚øćƒ¼ć‚ŗ ć‚Ø惫ć‚Øćƒ«ć‚·ćƒ¼ Substrates, devices and methods for assaying cells
US6806460B2 (en) 2002-05-31 2004-10-19 Agilent Technologies, Inc. Fluorescence detection with increased dynamic range
EP1509760A1 (en) 2002-05-31 2005-03-02 Gyros AB Detector arrangement based on surface plasmon resonance
US6952651B2 (en) * 2002-06-17 2005-10-04 Intel Corporation Methods and apparatus for nucleic acid sequencing by signal stretching and data integration
US20040018611A1 (en) * 2002-07-23 2004-01-29 Ward Michael Dennis Microfluidic devices for high gradient magnetic separation
US7452507B2 (en) 2002-08-02 2008-11-18 Sandia Corporation Portable apparatus for separating sample and detecting target analytes
US20040197845A1 (en) 2002-08-30 2004-10-07 Arjang Hassibi Methods and apparatus for pathogen detection, identification and/or quantification
US7364848B2 (en) * 2002-09-02 2008-04-29 Pamgene B.V. Integrated microarray analysis
US6923895B2 (en) * 2002-09-09 2005-08-02 Beckman Coulter, Inc. Coated capillary electrophoresis tubes and system
US6737742B2 (en) 2002-09-11 2004-05-18 International Business Machines Corporation Stacked package for integrated circuits
JPWO2004029241A1 (en) * 2002-09-24 2006-01-26 ę¾äø‹é›»å™Øē”£ę„­ę Ŗ式会ē¤¾ Method for amplifying nucleic acid by electromagnetic induction heating, reaction vessel and reaction apparatus used therefor
US7074598B2 (en) 2002-09-25 2006-07-11 Mayo Foundation For Medical Education And Research Detection of vancomycin-resistant enterococcus spp.
US7074599B2 (en) 2002-09-27 2006-07-11 Mayo Foundation For Medical Education And Research Detection of mecA-containing Staphylococcus spp.
TWI230257B (en) * 2002-10-01 2005-04-01 Univ Nat Cheng Kung Integrated analytical biochip and manufacturing method thereof
EP1546412B1 (en) * 2002-10-02 2014-05-21 California Institute Of Technology Microfluidic nucleic acid analysis
JP3813566B2 (en) * 2002-10-15 2006-08-23 ę Ŗ式会ē¤¾ć‚Øćƒ³ćƒ—ćƒ©ć‚¹ Resin chip
DE10258398A1 (en) 2002-12-11 2004-08-12 Hans-Knƶll-Institut fĆ¼r Naturstoff-Forschung e.V. DNA amplification method
US20050042639A1 (en) * 2002-12-20 2005-02-24 Caliper Life Sciences, Inc. Single molecule amplification and detection of DNA length
AU2003303594A1 (en) 2002-12-30 2004-07-29 The Regents Of The University Of California Methods and apparatus for pathogen detection and analysis
WO2004065995A2 (en) * 2003-01-23 2004-08-05 Alpha Innotech Corporation Identifying indicia and focusing target
US20040178971A1 (en) 2003-03-10 2004-09-16 Goodart Joseph Edgar Enhanced brightness, color and contrast control for cathode ray tube monitor
DE10315074A1 (en) * 2003-04-02 2004-10-14 Clondiag Chip Technologies Gmbh Device for the duplication and detection of nucleic acids
RU2005141456A (en) * 2003-06-06 2006-06-10 ŠœŠ°Š¹ŠŗрŠ¾Š½ŠøŠŗс, Š˜Š½Šŗ. (Us) SYSTEM AND METHOD OF HEATING, COOLING AND THERMAL CYCLING IN A MICRO-LIQUID DEVICE
US6864571B2 (en) * 2003-07-07 2005-03-08 Gelcore Llc Electronic devices and methods for making same using nanotube regions to assist in thermal heat-sinking
US7205111B2 (en) 2003-07-24 2007-04-17 Marshfield Clinic Rapid identification of bacteria from positive blood cultures
US7150299B2 (en) 2003-09-12 2006-12-19 Air Products And Chemicals, Inc. Assembly and method for containing, receiving and storing fluids and for dispensing gas from a fluid control and gas delivery assembly having an integrated fluid flow restrictor
US7541166B2 (en) * 2003-09-19 2009-06-02 Microfluidic Systems, Inc. Sonication to selectively lyse different cell types
WO2005029062A2 (en) 2003-09-22 2005-03-31 Shimadzu Corporation Electrophoretic member electrophoretic device electrophoretic method and sample dispensing probe
US20050074784A1 (en) * 2003-10-07 2005-04-07 Tuan Vo-Dinh Integrated biochip with continuous sampling and processing (CSP) system
JP2005117988A (en) * 2003-10-17 2005-05-12 Thermogen Kk Device for amplifying dna
US20050109621A1 (en) * 2003-11-26 2005-05-26 Peter C. Hauser Method and apparatus for performing high-voltage contactless conductivity (HV-CCD) electrophoresis
GB2416030B (en) 2004-01-28 2008-07-23 Norchip As A diagnostic system for carrying out a nucleic acid sequence amplification and detection process
WO2005080606A1 (en) * 2004-02-18 2005-09-01 Xiaochuan Zhou Fluidic devices and methods for multiplex chemical and biochemical reactions
US7312036B2 (en) 2004-03-22 2007-12-25 Isis Pharmaceuticals, Inc. Compositions for use in identification of viral hemorrhagic fever viruses
WO2005104323A2 (en) 2004-03-30 2005-11-03 Purdue Research Foundation Improved microchannel heat sink
US7280204B2 (en) * 2004-04-08 2007-10-09 Purdue Research Foundation Multi-spectral detector and analysis system
US7741042B2 (en) 2004-04-19 2010-06-22 Genomictree, Inc. Method for preparing a DNA chip and use thereof
US20060009106A1 (en) * 2004-05-20 2006-01-12 Daiwbo Co., Ltd. Wiping sheet
US7799553B2 (en) 2004-06-01 2010-09-21 The Regents Of The University Of California Microfabricated integrated DNA analysis system
CN103884698B (en) * 2004-06-07 2017-04-12 先锋ē”Ÿē‰©ē§‘ęŠ€č‚”ä»½ęœ‰é™å…¬åø Optical lens system and method for microfluidic devices
EP1614466A3 (en) 2004-07-08 2006-05-10 Tecan Trading AG System and method to prevent air bubbles in a hybridization chamber
US7611840B2 (en) * 2004-08-03 2009-11-03 Agency For Science, Technology And Research Method and device for the treatment of biological samples
JP4483469B2 (en) * 2004-08-05 2010-06-16 ę—„ē«‹é›»ē·šę Ŗ式会ē¤¾ Electrophoresis device
WO2006018044A1 (en) 2004-08-18 2006-02-23 Agilent Technologies, Inc. Microfluidic assembly with coupled microfluidic devices
US8053214B2 (en) 2004-09-09 2011-11-08 Microfluidic Systems, Inc. Apparatus and method of extracting and optically analyzing an analyte from a fluid-based sample
CN101073002B (en) * 2004-09-15 2012-08-08 英ē‰¹åŸŗå› ęœ‰é™å…¬åø Microfluidic devices
KR100668304B1 (en) 2004-09-16 2007-01-12 ģ‚¼ģ„±ģ „ģžģ£¼ģ‹ķšŒģ‚¬ A device for the injection of PCR solution into a PCR channel and a PCR chip unit comprising the device
TWI273240B (en) 2004-09-27 2007-02-11 Univ Nat Cheng Kung Reverse transcription polymerase chain reaction chip
US20060166223A1 (en) 2005-01-26 2006-07-27 Reed Michael W DNA purification and analysis on nanoengineered surfaces
US20060216737A1 (en) * 2005-03-10 2006-09-28 John Bodeau Methods for multiplex amplification
US20060207880A1 (en) * 2005-03-15 2006-09-21 Joyce Timothy H Microfluidic devices and methods of using microfluidic devices
US7275682B2 (en) 2005-03-24 2007-10-02 Varian, Inc. Sample identification utilizing RFID tags
TWI252920B (en) * 2005-03-25 2006-04-11 Ind Tech Res Inst Method of fabricating an integral device of a biochip integrated with micro thermo-electric elements and the apparatus thereof
EP1710017B1 (en) 2005-04-04 2012-12-19 Roche Diagnostics GmbH Thermocycling of a block comprising multiple samples
TW200637919A (en) * 2005-04-21 2006-11-01 Tang Chun Nan With an intelligent controller PCR reactor
US9599611B2 (en) 2005-04-25 2017-03-21 Trustees Of Boston University Structured substrates for optical surface profiling
KR100695148B1 (en) 2005-05-02 2007-03-14 ģ‚¼ģ„±ģ „ģžģ£¼ģ‹ķšŒģ‚¬ Module for polymerase chain reaction and multiple polymerase chain reaction system
US20060257958A1 (en) * 2005-05-13 2006-11-16 Pronucleotein Biotechnologies, Llc Magnetically-assisted test strip cartridge and method for using same
US8206974B2 (en) 2005-05-19 2012-06-26 Netbio, Inc. Ruggedized apparatus for analysis of nucleic acid and proteins
CN101203744B (en) 2005-06-02 2011-06-29 博億ē”Ÿē‰©ęœ‰é™å…¬åø Laser micro array chip scanner
US7939252B2 (en) * 2005-06-17 2011-05-10 University Of South Carolina Direct quantification of gene expression using capillary electrophoresis with laser-induced fluorescence
US20070014699A1 (en) * 2005-06-23 2007-01-18 Beckman Coulter, Inc, Methods and apparatus for improving the sensitivity of capillary zone electrophoresis
US20070009382A1 (en) * 2005-07-05 2007-01-11 William Bedingham Heating element for a rotating multiplex fluorescence detection device
US20090148348A1 (en) 2005-08-11 2009-06-11 Eksigent Technologies, Llc Plastic surfaces and apparatuses for reduced adsorption of solutes and methods of preparing the same
WO2007021809A2 (en) * 2005-08-11 2007-02-22 Eksigent Technologies, Llc Microfluidic systems, devices and methods for reducing background autofluorescence and the effects thereof
JP2009511059A (en) 2005-10-11 2009-03-19 ćƒćƒ³ćƒ‡ć‚£ćƒ¼ćƒ©ćƒ– ć‚¤ćƒ³ć‚³ćƒ¼ćƒćƒ¬ć‚¤ćƒ†ćƒƒćƒ‰ Polynucleotide sample preparation device
US20070116607A1 (en) * 2005-11-23 2007-05-24 Pharmacom Microlelectronics, Inc. Microsystems that integrate three-dimensional microarray and multi-layer microfluidics for combinatorial detection of bioagent at single molecule level
US8097421B2 (en) 2005-12-29 2012-01-17 Intel Corporation Method for performing a multiplex immunoassay using label disassociation and an integrated substrate
US20070154895A1 (en) 2005-12-30 2007-07-05 Caliper Life Sciences, Inc. Multi-assay microfluidic chips
US7715001B2 (en) 2006-02-13 2010-05-11 Pacific Biosciences Of California, Inc. Methods and systems for simultaneous real-time monitoring of optical signals from multiple sources
TW200808975A (en) * 2006-04-28 2008-02-16 Basf Ag Molecular beacons for DNA-photography
US7629124B2 (en) * 2006-06-30 2009-12-08 Canon U.S. Life Sciences, Inc. Real-time PCR in micro-channels
ES2748134T3 (en) 2007-04-04 2020-03-13 Ande Corp Systems for rapid multiple amplification of target nucleic acids
JP5523327B2 (en) 2007-10-12 2014-06-18 惬ć‚Ŗ惋惃ć‚Æć‚¹ļ¼Œć‚¤ćƒ³ć‚³ćƒ¼ćƒćƒ¬ć‚¤ćƒ†ćƒƒćƒ‰ Integrated microfluidic device and method
US20090253181A1 (en) * 2008-01-22 2009-10-08 Microchip Biotechnologies, Inc. Universal sample preparation system and use in an integrated analysis system
NZ620826A (en) 2009-02-03 2015-09-25 Netbio Inc Nucleic acid purification
US9550985B2 (en) * 2009-06-15 2017-01-24 Netbio, Inc. Methods for forensic DNA quantitation
WO2011112746A2 (en) 2010-03-09 2011-09-15 Netbio, Inc. Unitary biochip providing sample-in to results-out processing and methods of manufacture

Also Published As

Publication number Publication date
ES2674101T3 (en) 2018-06-27
AU2008236691B2 (en) 2014-08-07
US20200070173A1 (en) 2020-03-05
US20170067100A1 (en) 2017-03-09
WO2009011942A3 (en) 2009-06-11
US20180169660A1 (en) 2018-06-21
EP2137522B1 (en) 2020-05-06
CA2682734A1 (en) 2008-10-16
KR20100036224A (en) 2010-04-07
AU2008236739B2 (en) 2014-05-29
KR101523260B1 (en) 2015-06-01
US20090020427A1 (en) 2009-01-22
US20110312614A1 (en) 2011-12-22
AU2014204426B2 (en) 2016-07-21
CA3135182A1 (en) 2008-10-16
WO2008124116A1 (en) 2008-10-16
CA2984820A1 (en) 2008-10-16
AU2014204426A1 (en) 2014-07-31
AU2008236691A1 (en) 2008-10-16
KR20150143860A (en) 2015-12-23
JP2014236742A (en) 2014-12-18
JP2018029586A (en) 2018-03-01
EP3626345A1 (en) 2020-03-25
JP2010523976A (en) 2010-07-15
EP3032251A1 (en) 2016-06-15
US8425861B2 (en) 2013-04-23
AU2014271310B2 (en) 2017-02-02
WO2009011942A2 (en) 2009-01-22
US8858770B2 (en) 2014-10-14
NZ605885A (en) 2014-05-30
US20090023603A1 (en) 2009-01-22
WO2008124064A1 (en) 2008-10-16
NZ602697A (en) 2014-05-30
EP3032251B1 (en) 2018-05-23
US8961765B2 (en) 2015-02-24
EP2137523A1 (en) 2009-12-30
ES2748134T3 (en) 2020-03-13
JP2014039562A (en) 2014-03-06
JP2013215195A (en) 2013-10-24
CA2682734C (en) 2017-11-07
JP2020078301A (en) 2020-05-28
JP2016025854A (en) 2016-02-12
AU2008236612A1 (en) 2008-10-16
JP6265948B2 (en) 2018-01-24
AU2008236739A1 (en) 2008-10-16
JP2010523116A (en) 2010-07-15
CA2984820C (en) 2021-12-07
US20170100718A1 (en) 2017-04-13
EP2137522A1 (en) 2009-12-30
JP5557733B2 (en) 2014-07-23
CA2682761A1 (en) 2008-10-16
US9366631B2 (en) 2016-06-14
KR20100029181A (en) 2010-03-16
CA2682758A1 (en) 2008-10-16
EP3284538A1 (en) 2018-02-21
EP3677905A1 (en) 2020-07-08
KR20100021565A (en) 2010-02-25
US9889449B2 (en) 2018-02-13
NZ580374A (en) 2012-06-29
CA2682758C (en) 2018-08-14
US20130155403A1 (en) 2013-06-20
US20090059222A1 (en) 2009-03-05
WO2008124104A1 (en) 2008-10-16
US20170225164A1 (en) 2017-08-10
US11110461B2 (en) 2021-09-07
CA3135182C (en) 2024-01-23
ES2797951T3 (en) 2020-12-04
JP5675338B2 (en) 2015-02-25
US20130032483A1 (en) 2013-02-07
KR101530943B1 (en) 2015-06-23
AU2014271310A1 (en) 2015-01-15
EP2155393B1 (en) 2019-09-04
US9994895B2 (en) 2018-06-12
CA2894945A1 (en) 2008-10-16
NZ580375A (en) 2012-02-24
JP6105525B2 (en) 2017-03-29
EP2155393A1 (en) 2010-02-24
AU2008236612B2 (en) 2014-09-04
US8018593B2 (en) 2011-09-13
US9494519B2 (en) 2016-11-15
CA2894945C (en) 2018-01-09
NZ580373A (en) 2013-02-22
US20180280981A1 (en) 2018-10-04
US11052398B2 (en) 2021-07-06
JP2010523115A (en) 2010-07-15

Similar Documents

Publication Publication Date Title
CA2682761C (en) Methods for rapid multiplexed amplification of target nucleic acids
TWI504750B (en) Methods for rapid multiplexed amplification of target nucleic acids
US20220315996A1 (en) Optical Instruments and Systems for Forensic DNA Quantitation
JP2022130735A (en) Method and apparatus for sequential amplification reaction
CN104662160A (en) Extreme PCR
WO2008061129A2 (en) Methods and compositions related to continuous flow thermal gradient pcr
JP2008148690A (en) Nucleic acid amplification method using microchip and microchip, and nucleic acid amplification system using the same
Wang et al. Towards a portable microchip system with integrated thermal control and polymer waveguides for realā€time PCR

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130328